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Abstract 
 
 
This study examined the effects of concurrent walking tasks and interlocutor distance on 
conversational speech production in fifteen individuals with idiopathic Parkinson’s 
disease (PD) and fourteen age-equivalent controls. Recent studies of speech in PD have 
demonstrated that changes in the behavioural conditions and the environmental context 
can have a powerful effect on the severity of speech symptoms in PD. This investigation 
focused on changes in speech intensity and speech rate in response to changes in walking 
speed and interlocutor distance. Results suggest that the introduction of a concurrent 
walking task significantly increased the conversational speech intensity of both controls 
and individuals with PD. When compared to sitting and talking or standing and talking, 
current walking and talking appeared to have an energizing effect on conversational 
speech intensity. In addition, walking faster was associated with a significant increase in 
conversational speech intensity relative to normal and slow walking speeds. These results 
provide important new information about the effect of concurrent walking on speech 
motor performance and speech symptom severity in PD. The potential energizing effect 
of concurrent walking conditions on conversational speech intensity may be an important 
consideration in the assessment and treatment of individuals with low speech intensity in 
PD.  
 
Keywords: Parkinson’s disease, speech intensity, speech rate, concurrent tasks, 
interlocutor distance, stride length, walking speed 
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Chapter 1 
 
1 Introduction 
 
1.1  Parkinson’s Disease 
 
Parkinson’s disease (PD) is a highly variable, chronic progressive neurological 
disorder characterized by a number of movement related symptoms. The four cardinal 
motor features of PD include resting tremor, muscle rigidity, bradykinesia or akinesia, 
and postural and gait instability (Darley, Aronson, & Brown, 1975). Additional motor 
features include hypomimia (masked face), dysphagia, dysarthria, shuffling gait, motor 
freezing, festination of gait movements, and reduced arm-swing during walking (Darley 
et al., 1975). There are also many non-motoric symptoms of PD, these include anxiety, 
fatigue, sleep disturbance, pain/numbness in limbs, as well as behavioral and mental 
symptoms such as depression, decreased motivation, slowed thinking, and a decline in 
cognition that can progress to dementia (Fahn, 2003).  
 Symptoms of PD result from the progressive degeneration of dopaminergic 
neurons in the substantia nigra (SN) located within the basal ganglia (BG) (Fahn, 2003). 
The SN is responsible for producing dopamine and transmitting it into the striatum (also 
located within the BG), where it is then released as a neurotransmitter that is responsible 
for smooth coordinated movement. Post-mortem analyses clearly show shrinkage and 
loss of the pigmented cells of the SN and degeneration in additional brain regions (Braak, 
2003). Symptoms do not typically appear until dopamine concentration has decreased by 
80%, which corresponds to a loss of approximately 50% - 60% of dopaminergic neurons 
 2 
(Hamani & Lozano, 2003; Bernheimer, Birkmayer, Hornykiewicz, Jellinger, & 
Seitelberger, 1973). 
A definitive diagnosis can only be confirmed post-mortem because there is no 
biomarker that can identify the disease in a living person. Currently PD diagnosis is 
based on the presence of at least two of the four cardinal motor features and a good 
response to levodopa medication (Cooperman, Forwell, & Hugos, 2002; Dirette, 2000; 
Lim, Van Wegen, de Goede, Jones, Rochester, Hetherington, Nieuwboer, Willems, & 
Kwakkel, 2005). Melvin Yahr and Margaret Hoehn were the first to develop a system for 
grading severity of PD (Hoehn & Yahr, 1967). There are a number of scales to describe 
disease progression and response to treatment in PD, such as the Modified Hoehn and 
Yahr Scale, Unified Parkinson’s Disease Rating Scale (UPDRS), Schwab & England 
Activities of Daily Living scale, and the Parkinson’s disease Questionnaire (PDQ-39).  
 PD is a complex disorder, and the exact cause of neural degradation is still 
unknown. Studies suggest that multiple etiologies occur in PD, involving interactions 
among age, gender, environmental, and genetic factors (Korell & Tanner, 2005). Strong 
evidence suggests that the risk of PD increases with age, and that prevalence is 
consistently higher in men than women (1.5:1) (Korell & Tanner, 2005; Tanner & 
Goldman, 1996; Wirdefeldt, Adami, Cole, Trichopoulos, & Mandel, 2011). A number of 
methods have been used to assess the genetic contribution of PD, such as twin studies, 
familial studies, and genetic association studies (Wirdefeldt et al., 2011). Twin studies 
suggest low concordance rates, while familial studies indicate that family history is a 
strong risk factor for PD (Wirdefeldt et al., 2011). Genetic association studies have 
shown fairly consistent evidence that some genes are more important for susceptibility of 
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PD (Wirdefeldt et al., 2011). A number of studies also suggest increased risk of PD to 
particular occupational and environmental factors (see Wirdefeldt et al. (2011) for 
review). Wirdefeldt et al. (2011) examined particular exposures of interest and 
categorized their epidemiological evidence (Wirdefeldt et al., 2011). According to this 
analysis, evidence is limited on the role of metals, organic solvents, magnetic fields, and 
increased body mass index on increasing the risk of PD, while more suggestive evidence 
was found for pesticides and the intake of dairy products (Wirdefeldt et al., 2011). Coffee 
and smoking were both found to reduce the risk of PD (Wirdefeldt et al., 2011). 
 PD typically develops in older adults (50 to 70 years old, with the mean age of 
60) although it has affected individuals as young as 30 to 40 years old. According to 
Parkinson Society Canada (2010), approximately 100,000 Canadians currently live with 
the disease, and this is projected to double by 2016. The prevalence in the general 
population is estimated to be between 1 and 2 cases per 1,000 (Weiner & Lang, 1989). For 
individuals aged 65 and older the prevalence rises to approximately 10 in 1,000 (Tanner 
& Goldman, 1996).  
 
1.2 Hypokinetic Dysarthria 
 
It is estimated that 60-80% of individuals with PD will develop a speech 
impairment directly related to PD (Adams & Dykstra, 2009). Hypokinetic dysarthria is a 
motor speech disorder that is most commonly associated with PD (Adams & Dykstra, 
2009), although it can manifest in other neurodegenerative disorders such as progressive 
supranuclear palsy (PSP), Shy-Drager syndrome, and multi-system atrophy (MSA). The 
term dysarthria is the collective name for a variety of speech disorders involving any or 
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all of the basic speech processes, including respiration, phonation, resonance, 
articulation, and prosody (Blanchet, 2002). The term ‘hypokinesia’ describes the nature 
of the movement disorder and generally refers to reduced range and force of movement. 
Hypokinetic speech is characterized by reduced range of oral movements, slowed speed 
of single movements, increased speed of repetitive movements with limited range, and 
reduced force of movement of the speech articulators (Darley et al., 1975).  
The most distinctive features of hypokinetic dysarthria were originally reported 
by Darley, Aronson and Brown (1969a), and include a reduction in pitch range and 
inflections (monopitch), reduced stress on stressed syllables, monoloudness, imprecise 
consonants, inappropriate silences, short rushes of speech, variable speech rate, and 
harsh/breathy voice quality. An additional feature that was not in the original description 
is low speech intensity (hypophonia). Overall, speech in PD is attenuated in range, and 
restricted in speed and flexibility (Duffy, 2005). These speech symptoms often impair 
effective communication, as they have a negative impact on speech intelligibility, social 
functioning and emotional well-being (Miller, Noble, & Jones, 2006; Sapir, Spielman, 
Ramig, Story, & Fox, 2007). These communication impairments ultimately affect the 
quality of life in individuals with PD (Schrage, Jahanshahi, & Quinn, 2000).  
 
1.3 Speech Intensity associated with Hypokinetic Dysarthria 
 
It is estimated that 40-50% of individuals with hypokinetic dysarthria will present 
with low speech intensity (hypophonia), and it is often the first speech symptom to 
become apparent in the early stages of the disease (Adams, Winnell, & Jog, 2010). 
Hypophonia is associated with a reduction in speech intensity of 2-5dB relative to healthy 
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older adults (Adams et al., 2010). Many studies have investigated the nature of 
hypophonia in the speech of individuals with PD, and the various contexts and 
environments that exacerbate or minimize this effect. Ho, Iansek, and Bradshaw (1999b) 
found that individuals with hypophonia had a greater reduction in intensity when the 
speech output was more attentionally demanding (conversation) than when reciting well-
practiced sentences. Ho, Bradshaw, Iansek, and Alfredson (1999a), Ho, Bradshaw, and 
Iansek (2000), and Adams et al. (2010) investigated the ability of individuals with 
hypophonia to regulate speech intensity in background noise. These studies found that 
individuals with PD demonstrated relatively normal patterns of intensity regulation 
despite an overall reduction in intensity relative to controls. These studies also gave 
evidence that some individuals with PD have the same capacity for loud speech as 
healthy controls. In Adams et al.’s (2010) investigation, average speech intensity levels 
for control participants in quiet conditions were 70dB, while the PD participants had a 
speech intensity of 65dB in the same condition. When the PD participants were placed in 
an environment with 65dB of background noise, they were able to generate a speech 
intensity of 70dB. This provides evidence that individuals with PD can speak at intensity 
level appropriate for non-noisy conditions if cued properly.   
The pathophysiological mechanism that causes hypophonia in PD is still unclear. 
Some evidence suggests that the reduction in vocal intensity is directly related to a 
reduction in respiratory effort and a reduction in the adductory force of the vocal folds, 
resulting in insufficient pressure build-up to generate loud speech (Duffy, 2005). As a 
result, the primary goal of many behavioral speech treatments is to increase speech 
intensity by consciously training individuals to increase their vocal fold adductory force 
 6 
and their respiratory effort. In addition, it has been suggested that hypophonia may be 
linked to a perceptual deficit or a sensorimotor integration deficit (Ho et al., 2000).  For 
example, Ho et al. (2000) examined the perceived loudness of one’s own speech using 
immediate and delayed playback procedures and found that individuals with PD 
overestimated the perceived loudness of their own speech. This suggests that perceptual 
deficits may play a role in the hypophonia associated with PD.  
 
1.4 Speech Rate associated with Hypokinetic Dysarthria 
 
A number of previous studies have investigated typical habitual speaking rates in 
healthy and disordered populations. Venkatagiri (1999) found the speech rate of reading 
in young healthy adults to be 188.1 words per minute (WPM) or 262 syllables per minute 
(SPM), and the rate of discourse to be 143.3 WPM or 195.5 SPM. Lutz and Mallard 
(1986) reported similar findings for the speech rate of reading (198 WPM or 254 SPM) 
and discourse (158.6 WPM or 216.6 SPM). Similarly, Duchin and Mysak (1987) reported 
that the mean conversational speaking rate was 182.7 WPM or 236 SPM in healthy older 
adults.  
Rapid speaking rate is a prominent and distinctive perceptual feature of 
hypokinetic dysarthria (Duffy, 2005). A number of speech features characteristic of 
hypokinetic dysarthria, such as reduced stress on stressed syllables, imprecise consonant 
articulation, short rushes and inappropriate silences, create articulatory distortions in the 
speech signal. As a result, dysarthric speech is frequently perceived to be faster than it 
actually is (Yorkston, Hammen, & Beukelman, 1990). Many studies have investigated 
habitual speaking rates of individuals with hypokinetic dysarthria in PD, and results are 
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inconsistent. For example, a number of studies suggest that individuals with PD exhibit 
greater than normal speaking rates (McRae & Tjaden, 2002). However, these studies are 
primarily perceptual in nature, and attribute this perceived increase in speaking rate to a 
blurring of acoustic parameters in connected speech (McRae & Tjaden, 2002). In 
addition, there have been previous reports that speech in PD may be associated with a 
reduction in the size of the acoustic working space, which degrades perceptual 
impressions (Weismer, Jeng, Laures, Kent, & Kent, 2001; McRae & Tjaden, 2002). As a 
result, methods of rate reduction in PD have been a common treatment to improve speech 
intelligibility, as slowed speaking rates are associated with an expansion of acoustic 
working space (Weismer et al., 2001).  
In contrast, a number of studies have revealed that the speaking rate between 
individuals with PD and healthy adults is similar. For example, Walsh and Smith (2012) 
examined speaking rate in 16 individuals with PD and 16 control participants. Their 
findings demonstrate no significant difference between groups, however they reported 
that the PD participants had a larger range of speaking rate. Similarly, Flint, Black, 
Campbell-Taylor, Gailey and Levington (1992) examined speaking rate (syllables per 
second) of connected speech in 30 individuals with PD and 31 normal controls. Their 
findings suggest that both the PD and control groups have similar speaking rates for long 
passages. However, when reading short sentences, participants displayed a slight increase 
in speaking rate although this finding did not reach statistical significance. 
Based on this summary, it would appear that individuals with PD have a slightly 
faster speaking rate than healthy adults when reading shorter sentences, but as the length 
of connected speech increases (reading paragraphs and passages), speaking rate may 
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become more similar. Unfortunately, there is little information related to speaking rate 
during conversational speech in individuals with PD. 
 
1.5 Speech Intensity and Interlocutor Distance 
 
The ability to alter speech intensity with changes in interlocutor distance is an 
important aspect of natural communication. According to Zahorik and Kelly (2007), 
speech intensity obeys an inverse square law with distance. That is, when distance 
between speakers is doubled, there is a corresponding 6dB reduction in speech volume 
due to sound propagation losses. In healthy controls, Michael, Siegel and Pick (1995) 
suggested that speakers make prosodic, pragmatic and semantic changes in addition to 
increasing speech volume to accommodate changes in interlocutor distance. These 
compensatory changes are very similar to the ‘Lombard’ response, which explains that 
speech intensity is adjusted to compensate for increases in background noise. To facilitate 
effective communication, healthy controls adjust vocal output to compensate for the 
pragmatic demands of the speaking environment. 
A few previous studies have examined the ability of individuals with PD to 
regulate speech intensity in response to manipulations in interlocutor distance. Ho et al. 
(1999a) examined intensity regulation in both healthy controls and participants with PD 
for two speech tasks, conversation and reciting sentences. Despite an overall reduction in 
intensity, individuals with PD demonstrated relatively normal patterns of intensity 
regulation in response to changes in interlocutor distance. Interestingly, the overall 
reduction in intensity was more pronounced in the conversational speech task than when 
reciting sentences. The authors suggested that during conversation, less attention is 
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available for speech production. Similarly, Adams et al. (2010) found that healthy 
controls and individuals with PD produced similar changes in conversational speech 
intensity over changes in interlocutor distance. These previous studies suggest that 
changes in interlocutor distance may have a similar effect on speech intensity in PDs and 
controls and that the attentional demands of a speech task may influence this interlocutor 
distance effect. Unfortunately, no previous studies have attempted to systematically 
examine the potential interaction between changes in attention demands and changes in 
interlocutor distance. One potential method of investigating this interaction could involve 
the use of a dual-task paradigm (i.e., walking and talking) combined with variations in 
interlocutor distance.  
 
1.6 Concurrent Task Effects  
 
Despite the large body of research that has indicated consistent findings for 
concurrent task interference in normal participants, the factors that influence this 
interference are less well understood (Holmes, Jenkins, Johnson, Adams, & Spaulding, 
2010). Researchers in the field of cognitive psychology have examined concurrent task or 
divided attention phenomenon for several decades, and a number of theories have been 
developed to account for the task interference (or lack there-of) (Dromey & Shim, 2008). 
The capacity theories suggest that concurrent task interference occurs because the two 
tasks compete for attentional resources (‘attention’ refers to the focus of mental activity 
on a task) (Wu & Hallett, 2009), and thus one or both of the tasks will have a 
performance decrement. The time-sharing model suggests that attention is shifted back 
and forth between the two tasks in a series of smooth and rapid transitions, and the 
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functional distance hypothesis states that there will be less interference when the two 
tasks activate neural networks that are farther apart from one another (Dromey & Shim, 
2008).  
However, there have been reports of improved performance on one or both 
activities when performed concurrently. For example, the energizing hypothesis proposed 
by Adams et al. (2010) suggests that a concurrent motor task may improve the 
performance of a motor-speech task in individuals with PD. Recent studies on 
neurologically impaired participants have assessed the language-motor system interaction 
to determine whether performing an activity in one domain can facilitate the activity in 
another (Dromey & Shim, 2008; Meinzer, Breitenstein, Westerhoff, Sommer, Rosser, 
Rodriguez, Harnish, & Floel, 2011). Results suggest a link between linguistic functions 
and the activation of motor areas, indicating that these two systems share functional 
neural resources (Meinzer et al., 2011). For example, Meinzer et al. (2011) investigated 
the word retrieval performance of individuals with aphasia while sitting versus standing, 
and found improved performance while standing. The authors suggested that pre-
activation of the motor cortex could be used to excite the speech/language network. The 
enhancing or energizing effect of the language network has also been seen in healthy 
populations. For example, Dromey and Shim (2008) found that speech intensity increased 
in healthy controls when performed concurrently with a motor task.  
 
 
1.7 Concurrent Task Effects in Parkinson’s Disease 
 
Performing two tasks simultaneously is a common and typically unconscious 
activity of daily living, for example, talking while walking. To successfully perform tasks 
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concurrently, the body relies on several regions of the cerebral cortex and the basal 
ganglia. The cerebral cortex is believed to be responsible for controlling conscious motor 
activities, such as the acquisition of a new motor skill. As these motor activities become 
habitual, they are thought to be controlled unconsciously by the basal ganglia (Seitz & 
Roland, 1992). Idiopathic PD results from basal ganglia dysfunction, and as a 
consequence, task automaticity is reduced and cognitive resources must be drawn on to 
maintain performance of both tasks. Studies investigating the impact of concurrent tasks 
on gait in PD reveal lack of automaticity and increased cognitive demands (Rochester, 
Nieuwboer, Baker, Hetherington, Willems, Kwakkel, Wegen, Lim, & Jones, 2008). 
Consequently, individuals with basal ganglia dysfunction will have difficulty coping with 
concurrent tasks, and performance deficits are often exacerbated in individuals with PD 
(Rochester et al., 2008).  
 
1.8 Speech and Concurrent Tasks in Parkinson’s Disease 
 
Speech tasks have been primarily included as a dual-task paradigm for cognitive 
loading in studies investigating gait in individuals with PD. As a result, the emphasis in 
data collection and analysis has been primarily focused on gait performance, and not on 
the speech performance. The few studies that have provided analysis for the speech task 
have been inconsistent, and the type of speech task may explain this variability. For 
example, Galletly and Brauer (2005) had participants with idiopathic PD walk for ten 
minutes at a comfortable pace while performing serial-3 subtraction and verbal fluency 
tasks. Both speech tasks improved significantly when performed concurrently with the 
walking task (16% and 73% respectively), while there was a decrement in walking 
performance. A similar study by O’Shea, Morris, and Iansek (2002) found a decrement in 
 12
both speech (serial-3 subtraction) and walking task. In addition, a study by Yogev, 
Giladi, Peretz, Sprinter, Simon, and Hausdorff (2005) had participants with PD walk for 
two minutes down a 25-meter corridor at a comfortable pace while performing separate 
verbal-cognitive tasks: listening to a tape and answering questions, and performing serial-
3 subtraction. Results demonstrated performance decrements in both the speech and 
walking task. In all studies, speech performance was quantified as the percentage of 
errors in the serial subtraction tasks. Unfortunately, these measures of speech 
performance reflect speech from a language perspective, and do not reflect a motor 
speech perspective or a speech acoustic perspective.  
Only two studies have been conducted to determine the effects of a concurrent 
task that is specifically focused on motor speech production in PD, and the results are 
inconsistent. Ho, Iansek, and Bradshaw (2002) examined the effect of a concurrent 
manual task on speech intensity in individuals with PD using two speech tasks, 
conversation and a loud numerical recitation task.  The concurrent task in this study was a 
visuomotor manual tracking task, which required participants to monitor the position of a 
randomly moving target with a joystick.  Results indicated a significant decrease in 
speech intensity during the loud number recitation speech task but not during 
conversational speech. Adams et al. (2010) examined conversational speech intensity 
while participants performed a concurrent visuomotor manual tracking task in which 
participants tracked a moving target with a handheld bulb in various interlocutor 
distances and multi-talker background noise conditions. The PD participants produced a 
significant increase in conversational speech intensity while performing the concurrent 
motor task, while the healthy controls produced a significant reduction in speech 
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intensity. The authors suggested that certain concurrent tasks might have an energizing 
effect on speech intensity in individuals with PD. In addition, the authors suggest that an 
increase in speech intensity seen during the concurrent manual task might have been the 
result of “an overall increase in effort” that was caused by the introduction of a 
concurrent task (Adams et al., 2010; Dromey & Bates, 2005; Dromey & Shim, 2008). 
There have been a few previous reports that examined the relationship between 
concurrent motor tasks and speech intensity in healthy controls. In two studies of healthy 
young controls, Dromey and Bates (2005) and Dromey and Shim (2008) found that a 
concurrent manual task was associated with a significant increase in the speech intensity 
of spoken sentences at typical conversational intensity. Gentilucci, Benuzz, Gangitano, 
and Grimaldi (2001) investigated the effect of grasping an object on syllable production, 
and found that increases in the size of concurrent hand grasping movements were 
associated with increased speech intensity. In addition, Gentilucci (2003) examined 
‘observed’ grasp movements on syllable production and found similar results. The 
authors suggest that the cortical areas responsible for observation and preparation of 
grasp movements are partially shared with the cortical areas involved in speech 
production.  
Many concurrent task studies investigating motor speech performance have 
employed simple motor tasks involving the upper extremities (e.g., finger-tapping, motor 
tracking), but it is difficult to extrapolate from these to typical human behavior (Dromey 
& Shim, 2008). For example, O’Shea et al. (2002) state that upper limb movements are 
primarily controlled by motor cortical regions and require attention, visual guidance and 
somatosensory feedback to control their performance. In contrast, locomotion consists of 
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highly pre-programmed movements, and is thought to be regulated at the brainstem, 
spinal, and cerebellar regions (O’Shea et al., 2002).  
 
1.9 Walking Performance and Concurrent Task Effects in Parkinson’s 
Disease 
It is estimated that 80-90% of individuals with PD will develop gait impairments 
within the first three years of diagnosis (Kang, Brostein, Masterman, Redeings, Crum, & 
Ritz, 2005). Decreased mobility and physical functioning have significant consequences 
on quality of life in PD, and are rated among the worst aspects of the disease (Schrag et 
al., 2000; Post, Merkus, J. de Haan, & Speelman, 2007; Kelly, Eusterbrock, & Shumway-
Cook, 2012).  
Walking in the real world is a very complex activity that requires cognitive 
flexibility to meet the changing demands of the environment (Rochester et al., 2008). 
This creates additional challenges for individuals with basal ganglia dysfunction (i.e., 
PD), as substantial conscious control is needed for the walking performance, making it 
difficult to adapt to the changing walking environment (Rochester et al., 2008). 
Consequently, individuals with gait impairments in PD experience further reductions in 
gait velocity and stride length, decreased symmetry and coordination of the stride pattern, 
and increased step time variability while dual-tasking (i.e., talking while walking) (Kelly 
et al., 2012).  
The association of gait impairments with adverse consequences like increased fall 
risk has motivated research in assessing the motor and cognitive factors that exacerbate 
or improve walking deficits in persons with PD (Kelly et al., 2012). Consequently, a 
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number of studies have investigated secondary tasks that may exacerbate or reduce the 
risk for falls in individuals with PD. For example, Morris, Iansex, Matyas, and Summers 
(1996) examined effects of both a set of verbal secondary tasks (sentence repetition) and 
a cognitive secondary task (reciting days of the week backwards) on gait in individuals 
with PD and age-matched controls. Results illustrated that, although the control group 
exhibited a slowing of the walking pattern, the changes were not statistically significant. 
In contrast, it was found that secondary task performance led to a significant decrement 
in stride length and stride velocity in the PD group that was proportional to the 
complexity of the task performed.  
 O’Shea et al. (2002) investigated the effects of motor versus cognitive secondary 
tasks on gait in PD and age-matched controls. The PD group had reduced stride length 
and step velocity than controls at baseline and when engaged in dual task situations, 
regardless of secondary task.  
Rochester, Hetherington, Jones, Nieuwboer, Willems, Kwakkel, and Van Wegen 
(2004) evaluated the effects of functional activities (cognitive and motor) in the home 
setting on walking performance in individuals with PD. The performance of secondary 
tasks resulted in a greater reduction of walking speed and stride length in PD, compared 
to age-matched controls. However, the cognitive task had greater deleterious effects on 
gait than the motor task. 
Consequently, when individuals with PD attempt dual tasking, their footsteps 
become short and slow (Galletly & Brauer, 2005; O’Shea et al., 2002), ground clearance 
reduced, and they become at an increased risk for falls (Bloem, Hausdorff, Visser, & 
Giladi, 2004; Morris et al., 1996). 
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1.10 Gait Hypokinesia in Parkinson’s Disease: Velocity and Stride Length 
 
Walking is a complex activity that requires multi-joint coordination and the 
ability to sequence joint angles and segments during motion (Rochester et al., 2008; Chiu 
& Chou, 2012). In healthy subjects, walking is automated and rhythmic, and limb 
movements are replicated from stride-to-stride while free walking (Morris, Iansek, 
Matyas, & Summers, 1994b). 
In PD, gait abnormalities are common and result from a combination of 
hypokinesia (slowness), rigidity, and deficiencies in posture and balance. (Knuttson, 
1972).  Gait in PD is often characterized by a shuffling gait with small steps, reduced 
amplitude of upper limb movements, and a stooped posture (Knuttson, 1972). There can 
also be problems with initiation of gait, difficulty turning and freezing of gait (Tan, 
Danoudis, McGinley, & Morris, 2012). Throughout the progression of the PD, gait 
abnormalities can lead to an increased fall risk, loss of mobility, and loss of independence 
(Morris et al., 1994b).   
Previous studies have shown that individuals with PD have a reduced gait velocity 
of 25-40%, and reduced stride length of 15-27% relative to control participants 
(Rochester, Hetherington, Jones, Nieuwboer, Willems, Kwakkel, & Van Wegen, 2005; 
O’Shea et al., 2002; Morris, Iansek, Matyas, Summers, 1994a; Morris et al., 1994b; Mak, 
2013). A number of previous studies have revealed that the regulation of stride length is 
the fundamental deficit of gait hypokinesia in PD (Morris et al., 1994a b; Mak, 2013). 
For example, Morris et al. (1994b) investigated stride length, gait velocity, and stride 
cadence in individuals with gait hypokinesia in PD. In experiments where velocity is not 
controlled, individuals with PD have a reduced stride length and cadence, and an overall 
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reduction in gait velocity relative to control participants. However, when velocity is 
controlled, individuals with PD have a higher walking cadence and shorter stride length 
relative to controls (Mak, 2013). The authors suggest that the increase in cadence is a 
compensatory mechanism for the reduced stride length (Morris et al., 1994b). In general, 
individuals with PD can more easily regulate gait velocity and cadence, and have 
problems regulating stride length.  
The underlying mechanism responsible for stride length regulation in gait 
hypokinesia is not well understood. Learned movements, such as walking, require 
internal cues of the basal ganglia to string the movement sequence together. Growing 
evidence in PD suggests that the internal cue mechanism is defective, leading to the 
disordered preparation of submovements in the walking sequence (Morris et al., 1994a). 
In support of this, a number of investigations have found that when provided with 
external cues, such as auditory or visual cues, disordered participants can achieve normal 
movement size (Beradelli, Accornero, Argenta, Meco, & Manfredi, 1986a; Sheridan, 
Flowers, & Humell, 1987; Morris et al., 1994b). For example, Morris et al. (1994b) found 
that when provided with floor markers, individuals with PD were able achieve normal 
stride length values. These findings suggest that the step pattern is still intact in 
individuals with PD and that the problem of stride length regulation is related to difficulty 
activating the correct stepping response (Morris et al., 1994b).  
A number of previous studies have shown that typical gait velocity values of 
healthy control participants are between 0.88 and 1.36 meters per second. In contrast, 
individuals with gait hypokinesia in PD demonstrate gait velocity values between 0.56 
and 0.85 meters per second (Morris et al., 1994 a b; Maggioni, Veicsteinas, Rampichini, 
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Ce, Nemni, Riboldazzi, & Merati, 2011; Rochester et al., 2005; Knuttson, 1972; Murray, 
Sepic, Gena, Gardner, & Downs, 1978). Some of the inconsistency in these gait velocity 
values may be related to the severity of PD across these previous studies. For example, 
Murray et al. (1978) demonstrated that PD participants with mild to moderate 
parkinsonian symptoms had walking speeds of 0.82 to 0.95 meters per second, while 
more severe participants had walking speeds of approximately 0.67 meters per second. In 
addition, these studies have shown that typical stride length values of healthy control 
participants are approximately 1.24 to 1.47 meters, while stride length values of PD 
participants is approximately 0.75 to 0.92 meters (Morris et al., 1994 a b; Knuttson, 
1972).  
The effect of changes in walking speed on locomotive parameters such as gait 
velocity, stride length and cadence has also between investigated (Morris et al., 1994a b; 
Mak, M., 2013; Maggioni et al., 2011; Murray et al., 1978). The purpose of these studies 
has primarily been to investigate whether stride length and cadence of disordered 
participants will approximate normal levels when velocity is controlled or equalized. In 
general, findings demonstrate that PD participants undershoot or underestimate gait 
velocity, relative to controls, at all walking speeds. For example, at self-selected fast 
walking speeds, mean gait velocity is approximately 1.42 – 1.87 meters per second for 
control participants, while PD participants have a mean gait velocity of approximately 
0.92 – 1.35 meters per second. Maggioni et al. (2011) investigated the maximal speed of 
control and PD participants and found that control and PD participants achieved mean 
gait velocities of 5.68 and 4.38 meters per second respectively. This suggests that 
individuals with PD have the capacity for fast walking, however they are consistently 
 19
slower than control participants. In addition, Morris et al. (1994b) demonstrated similar 
findings when they had PD and control participants walk at slower than normal gait 
velocities. Control participants reduced their mean gait velocity to 0.78 meters per second 
from their normal self-selected speed of 1.08 meters per second (a 28% reduction), while 
PD participants reduced their mean gait velocity from 0.75 meters per second to 0.58 
meters per second, a 22% reduction. 
In addition, stride length values for faster walking speeds were found to be greater 
for both PD and control participant groups. However, PD participants made a relatively 
greater increase in their stride length relative to controls. For example, Morris et al. 
(1994b) demonstrated that when shifting from normal to fast walking speeds, the mean 
stride length of the PD participants showed a relative increase of 15% (from 0.92m to 
1.06m) while the mean stride length of the control participants only showed a relative 
increase of 10% (from 1.3m to 1.43m). Although it should be noted that, in terms of the 
change in absolute stride length values, the PD and control participants showed a fairly 
similar increase in stride length across the shift from normal to fast walking speeds (PD = 
+0.14m; controls = +0.13m).  
 
1.11 Rationale 
 
 A number of studies have looked at the effects of a concurrent speech task on 
walking performance in individuals with idiopathic Parkinson’s disease (see Kelly et al. 
(2012) for review). Most of these studies have included serial counting, backward 
counting or verbal fluency tasks.  The use of a monologue or conversational speech task 
has rarely been examined in these concurrent walking and speech studies. In addition, the 
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performance measures obtained from the speech production tasks have typically been 
limited to measures of language performance rather than measures of speech motor 
performance (i.e. speech rate) or speech acoustic measures (i.e. speech intensity).  This is 
unfortunate, because a few previous studies have indicated that there can be significant 
effects on speech intensity during concurrent tasks involving manual activities (Ho et al., 
2002, Adams, et al., 2010). Adams et al. (2010) found an increase in the speech intensity 
of PD participants during a concurrent manual task and proposed the energizing 
hypothesis to explain this enhancing effect. The potential effect of other concurrent motor 
activities, such as walking, needs to be examined. Finally, previous studies suggest that 
attentional demands of a speech task may influence the effect of interlocutor distance on 
speech intensity in PD (Ho et al., 1999a; Adams et al., 2010). Unfortunately no previous 
studies have attempted to systematically examine the potential interaction between 
changes in attention demands (i.e., concurrent task effects) and changes in interlocutor 
distance.  
 
1.12 Objectives 
1. To examine conversational speech intensity and speech rate in individuals with 
Parkinson’s disease and controls.  
2. To examine the effect of several concurrent walking and non-walking tasks on 
conversational speech intensity and speech rate in Parkinson’s and controls. 
3. To examine the effect of different concurrent walking speeds on conversational 
speech intensity and speech rate in Parkinson’s and controls.  
4. To examine the effects of different interlocutor distance on conversational speech 
intensity and speech rate in Parkinson’s and controls. 
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5. To examine the interaction between different concurrent walking tasks and 
interlocutor distances on the conversational speech intensity and speech rate of 
Parkinson’s and controls.  
6. To examine the effect of concurrent walking tasks and conversational speech on 
walking speed and stride length in Parkinson’s and controls. 
7. To examine the combined effects of concurrent walking tasks, interlocutor 
distances and conversational speech on walking speed and stride length in 
Parkinson’s and controls.  
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Chapter 2 
 
2 Methods 
 
2.1 Participants 
 
This study included 15 participants (2F, 13M) between 58 and 80 years old  
(M = 72.07) diagnosed with mild to moderate idiopathic Parkinson’s disease and 
hypophonia and hypokinetic dysarthria as reported by a neurologist. Participants with PD 
were patients of neurologist Dr. Mandar Jog at the Movement Disorders Clinic in the 
Department of Clinical Neurological Sciences at the London Health Sciences Centre 
(LHSC), and were recruited by Dr. Scott Adams and Cassandra McCaig. Participants 
with PD were stabilized on their anti-Parkinson medications, and tested approximately 
one to two hours after the regular self-administration of their medication. Three of the 
participants with PD were not on anti-Parkinson medication. PD participant demographic 
information is listed in Table 1. The study also included 14 age-equivalent healthy 
control participants (7M, 7F) between 59 and 82 years old. The control participants were 
recruited from the Retirement Research Association and the Centre for Activity and 
Aging by Dr. Scott Adams and Cassandra McCaig. The control participants were in good 
overall health, with an absence of any speech, language, hearing (with the exception of 
C10, however hearing loss was compensated for by the use of hearing aids) or 
neurological impairments.  
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Table 1. PD Participant Demographic Information 
Participant Age Gender Years 
since 
diagnosis 
Mini-
Mental 
Score 
Parkinson 
Medication 
Previous 
Occupation 
PD1 73 M 6 29 Sinemet Account 
Manager 
PD2 80 M 2 29 None Mechanic 
PD3 70 M 16 30 Sinemet Engineer 
PD4 62 M 17 30 Sinemet Lumber 
Yard Sales 
PD5 74 M 16 27 Sinemet Printing 
PD6 76 F 17 30 Sinemet Teacher 
PD7 76 M 3 27 Sinemet High School 
Teacher 
PD8 74 M 17 30 Sinemet London Life 
Manager 
PD9 78 M 4 29 Levocarb Engineer 
PD10 67 M 7 30 Sinemet N/A 
PD11 78 M 8 22 Sinemet Veterinarian 
PD12 75 F 11 28 None Housewife 
PD13 73 M 3 30 Sinemet Heavy 
Equipment 
Operator 
PD14 58 M 1 30 None Controller 
PD15 63 M 3 28 Sinemet Technician 
 
 
 
Table 2. Control Participant Demographic Information 
Participant Age Gender Previous Occupation 
C1 59 M Language Consultant 
C2 61 F Housewife 
C3 86 M Production Methods Engineer 
C4 73 M Fanshawe Instructor 
C5 73 F N/A 
C6 82 M Armed Forces, Music 
Instructor 
C7 76 F N/A 
C8 73 M High School Teacher 
C9 61 M Retired 
C10 66 F Social Worker 
C11 65 F N/A 
C12 77 F Secretary 
C13 80 F Nurse 
C14 72 M Field Safety Inspector 
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Prior to testing, all participants were given a letter of information (Appendices A 
and B) about the study, along with a consent form (Appendix C) before agreeing to 
participate. All participants passed a 40 dB HL hearing screening (tested at 500 Hz, 1000 
Hz, and 2000 Hz). None of the participants reported previous history of speech, language, 
or neurological disorder other than PD. In addition, all PD participants passed a cognitive 
screening (Mini Mental Status Examination). This study was approved by the Health 
Sciences Research Ethics Board at the University of Western Ontario (Appendix D). 
 
2.2 Apparatus 
 
  Conversational Data Acquisition. Each PD and control participant completed all 
of the experimental procedures during a single, 60-minute session in the Althouse 
Gymnasium in Althouse College at the University of Western Ontario. The participant 
was equipped with an M-audio Microtracker II device, with a DPA 4060 miniature 
omnidirectional head-mounted microphone to record conversational speech. The 
microphone was placed approximately 6cm from the participant’s mouth. The 
microphone was calibrated by having the participant produce a sustained ‘ah’ for at least 
1 second at 70dB using a sound level meter placed 15cm from the participant’s mouth. 
This was repeated 3-times, and the average was used.  
   
Walking Data Acquisition. Two stationary video cameras were used to record 
each participant’s walking performance. One camera was placed parallel to the 
participant’s walking path, and a second video camera was placed perpendicular to the 
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participant’s walking path. The video recordings were used to measure walking speed 
(distance/time) and stride length (distance/number of steps).  
 
2.3 Experimental Protocol 
 
The experimental protocol began with the collection of the following supporting 
information: the Unified Parkinson Disease Rating Scale (Fahn et al., 1987) (PD group 
only); the Mini Mental Status examination to screen for dementia (PD group only); and 
an Intake Survey (Appendix E). The participant was then introduced to the walking task 
where they were familiarized with the walking pathway.  
 Each participant was asked to perform a variety of separate and concurrent 
speech and walking tasks for a total of 13 experimental conditions. The order of the 13 
conditions was randomized for each participant using an online random sequence 
generator (Haahr, 1998). The speech tasks involved engaging in a conversation with the 
experimenter for approximately 2-3 minutes about a familiar topic. The conversational 
topics included favourite vacations, interests, hobbies, relatives, occupational 
experiences, etc.  The conversations took place with the experimenter positioned at either 
a one-meter interlocutor distance from the participant or a 6-meter interlocutor distance. 
The walking tasks involved 5 different tasks. This included 1) sitting, 2) standing, 3) 
walking at a normal or habitual speed, 4) walking at a speed that is self-perceived to be 
two times slower than the habitual speed, and 5) walking at a speed that is self-perceived 
to be two times faster than habitual. The experimental conditions are outlined in Table 3.  
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Table 3. Outline of Experimental Protocol 
Condition Walking Task 
Interlocutor 
Distance 
(meters) 
Talking 
(YES/NO) 
1 Sitting 1 YES 
2 Sitting 6 YES 
3 Standing 1 YES 
4 Standing 6 YES 
5 Walking Normal 1 NO 
6 Walking Slow 1 NO 
7 Walking Fast 1 NO 
8 Walking Slow 1 YES 
9 Walking Slow 6 YES 
10 Walking Normal 1 YES 
11 Walking Normal 6 YES 
12 Walking Fast 1 YES 
13 Walking Fast 6 YES 
 
2.4 Data Measurement  
 
 Conversational Speech Intensity and Rate. All conversational speech 
recordings were transferred from the M-Audio Microtracker II device to a desktop 
computer running Praat (Boersma & Weenink, 2011) software. The acoustic waveform 
editing and analysis function in the Praat software were used to obtain two primary 
acoustic measures: average speech rate (words per minute) and average speech intensity 
(dB SPL). The first 10 conversational utterances (minimum 5 words in length) were 
analyzed from each experimental condition. The number of words per utterance was 
divided by the utterance duration (in minutes) in order to obtain a measure of speech rate 
(words per minute).  The estimates of speech rate and speech intensity were based 
exclusively on continuous (fluent) utterances and did not include pauses greater than 250 
milliseconds.  
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Walking Speed and Stride Length. To collect a measure of stride length the 
experimenter observed the perpendicular video recording and manually counted the 
number of steps in each 21-meter walking segment (end points marked by 2 meter 
vertical poles) for each walking condition. The number of steps was then divided by the 
distance of the walking segment (21 meters / # steps). To collect a measure of walking 
speed the experimenter would time the duration of each 21-meter walking segment on the 
perpendicular video recording using a stopwatch. The recorded time (seconds) was then 
divided by the distance of the walking segment (21 meters / time in seconds). The 
participant would typically walk along the 21-meter walking segment 2-3 times per 
walking condition, so the stride length and walking speed measurements were averaged 
across these repeated walks for each walking condition. The video recordings were 
analyzed using VLC media player, which allowed the examiner to zoom in on the video 
recording at any time. The zoom function was used when the participant would approach 
the vertical pole to collect the most accurate estimate of walking duration and number of 
steps. 
In addition, participants were asked to start walking approximately 2-3 meters 
prior to the first vertical pole, and to walk 2-3 meters past the second vertical pole before 
turning around. This ensured that participants maintained a constant speed while walking 
along the 21-meter walking segment.  
 
2.5 Data Analysis 
 
In order to assess the primary objective of this study investigating the effects of 
concurrent walking on conversational speech intensity and speech rate, two separate 
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three-way ANOVA’s were performed with the participant group (PD and control) as the 
between group factor, and walking task (sitting, standing, walking at a speed perceived 
by the participant to be two times slower than their normal or habitual speed, walking at a 
normal or habitual speed, and walking at a speed perceived by the participant to be two 
times faster than their normal or habitual speed) and interlocutor distance (one-meter and 
six-meters) as the within group factors.  
Each of the significant main effects were obtained in the ANOVAs investigating 
conversational speech intensity were examined in more detail using Bonferroni-corrected 
post-hoc t-tests. The first post-hoc t-test investigated the effect of walking speed on 
conversational speech intensity in both the PD and control groups. A second post-hoc t-
test investigated the effect of walking at a normal speed versus sitting or standing on 
conversational speech intensity in both the PD and control groups.  
 In order to assess the secondary objective of this study investigating the 
concurrent task effects on stride length and walking speed, two separate three-way 
ANOVA’s were performed with the participant group (PD and control) as the between 
group factor, and walking speed conditions (walking slow, walking normal, and walking 
fast) and talking condition (talking and not-talking) as the within group factors.  
 To investigate the effect of interlocutor distance on stride length and walking 
speed, two separate three-way ANOVA’s were performed with the participant group (PD 
and control) as the between group factor, and walking speed conditions (walking slow, 
walking normal, and walking fast) and interlocutor distance (1-meter and 6-meters) as the 
within group factors. 
Each of the ANOVAs were examined with a significance level of p= .05.  
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Chapter 3 
 
3 Results 
 
This study investigated the effects of concurrent walking tasks and interlocutor 
distance on conversational speech intensity and speech rate in individuals with 
Parkinson’s disease, and healthy age-equivalent controls. The primary results of this 
study will be presented in two main sections based on the two primary variables being 
assessed: conversational speech intensity, and conversational speech rate. For each of 
these two variables, the results will be presented with regard to the group effect (PD 
versus control), the effect of the walking conditions, and the effect of the interlocutor 
distance conditions. 
A secondary analysis examined the effect of talking versus not talking on the 
walking performance in individuals with PD and the healthy age-equivalent controls. The 
results of this secondary analysis will be grouped into two main sections that are based on 
the two walking variables being assessed: walking speed and stride length. For each of 
these two walking variables, the results will be presented with regard to the group effect 
(PD versus control), the effect of the walking conditions, and the effect of the interlocutor 
distance conditions.  
 
3.1 Conversational Speech Intensity  
 
 One of the primary objectives of this study was to examine the effect of 
concurrent walking tasks on conversational speech intensity in individuals with 
Parkinson’s disease and healthy age-equivalent controls. A three factor, repeated 
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measures ANOVA was performed using participant group as the between groups factor 
with two levels (control, PD). The two within-group factors included interlocutor 
distance and the type of walking task. The interlocutor distance factor had two levels (one 
meter and six meters interlocutor distance). The factor related to the type of walking task 
had five levels (sitting, standing, walking at a speed perceived by the participant to be 
two times slower than their habitual walking speed, walking at a habitual walking speed, 
and walking at a speed perceived by the participant to be two times faster than their 
habitual walking speed). The results of the three-way ANOVA are presented in separate 
sections related to the main effects (group, interlocutor distance, walking task), the 
interactions, and the post-hoc comparisons. The results are summarized in Figures 1 and 
2 with associated means and standard deviations listed in Tables 4 and 5. The detailed 
results of the three-way ANOVA related to speech intensity are presented in Appendix F. 
 
Table 4. Average Conversational Speech Intensity Values by Walking Condition at 
an Interlocutor Distance of One Meter 
Control PD 
Sitting 69.76 (2.64) 65.58 (3.55) 
Standing 69.31 (2.67) 64.23 (3.81) 
Walking Slow 71.33 (2.52) 67.61 (4.53) 
Walking Normal 71.85 (2.45) 68.24 (3.25) 
Walking Fast 73.41 (2.87) 69.79 (3.43) 
*Note: speech intensity levels are in dB SPL. Standard deviations appear in parentheses beside means. 
 
 
 Figure 1. Average conversational speech intensity values by walking condition at an 
interlocutor distance of one meter
 
 
 
Table 5. Average Conversational Speech Intensity Values by Walking Condition
an Interlocutor Distance of Six Meters
Sitting 
Standing 
Walking Slow
Walking Normal
Walking Fast
*Note: speech intensity levels are in dB SPL. Standard deviations appear in parentheses beside means.
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. Standard deviations appear as error bars.
 
Control PD 
72.91 (2.22) 68.65 (3.66) 
72.25 (2.51) 68.09 (3.59) 
 74.14 (2.87) 70.36 (3.49) 
 74.30 (2.48) 70.28 (3.18) 
 75.73 (3.02) 70.84 (3.40) 
Walking 
Slow
Walking 
Normal
Walking 
Fast
Control
Parkinson's
 
 
 at 
 
 Figure 2. Average conversational speech intensity values by walking condition at an 
interlocutor distance of six meters
 
 
3.1.1 Main Effects: Group, Interlocutor Distance, and Walking Condition
 
 The main effect of group was significant (
illustrated in Figure 3 with associated means and standar
This significant main effect for group indicates that across all of the experimental 
conditions the individuals with Parkinson’s disease had an overall conversational speech 
intensity level that was approximately 4.1 dB lower than the
controls.  
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. Standard deviations appear as error bars.
F(1,21) = 11.32, p = 0.003) and is 
d error scores listed in Table 6
 healthy age-equivalent 
Walking 
Slow
Walking 
Normal
Walking 
Fast
Control
Parkinson's
 
 
s 
. 
 Table 6. Average Conversational Speech Intensity Values
*Note: speech intensity levels are in dB SPL. Standard errors appear in parentheses below means.
 
 
 
 
Figure 3. Average conversational speech intensity values
as error bars. 
 
 
 
The main effect of interlocutor distance was significant [
0.000] and is illustrated in Figure 4 with associated means and standar
in Table 7. This significant main effect for interlocutor distance indicates that both 
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Control PD 
72.31 68.17 
(0.85) (0.89) 
 
. Standard error scores 
F(1,31) = 103.23, p = 
d error scores listed 
PD
 
appear 
 participant groups significantly increase conversational spee
increase in interlocutor distance. 
 
Table 7. Average Conversational Speech Intensity of Control and PD Participants at 
an Interlocutor Distance of One and Six Meters
*Note: speech intensity levels are in dB SPL. Standard errors appear in parentheses below means.
 
 
Figure 4. Average conversational speech intensity of control and PD participants at 
an interlocutor distance of one and six meters
error bars. 
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1 meter 6 meters 
69.02 71.46 
(0.64) (0.61) 
 
. Standard error scores appear as 
6 meters
 
 The main effect of the walking task was significant [
and is illustrated in Figure 5 with associated means and standar
Table 8. This significant main effect of walking task indicates that the type of concurrent 
walking task significantly effects conversational speech intensity in both part
groups.  
 
Table 8. Average Conversational Speech Intensity Values Across Walking 
Conditions 
Sitting Standing 
69.01 68.40 
(0.64) (0.67) 
*Note: speech intensity levels are in dB SPL. Standard errors appear in parentheses below means.
 
 
Figure 55. Average conversational speech intensity values across walking conditions
Standard error scores appear as error bars.
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F(4, 18) = 32.90, p = 0.000] 
d error scores listed in 
Walking Slow Walking Normal Walking Fast
70.51 71.00 
(0.68) (0.56) 
 
 
Walking Slow Walking Normal Walking Fast
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72.28 
(0.65) 
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3.1.2 Interactions Related to Intensity: Group, Interlocutor Distance, and Walking 
Conditions 
The result for the interlocutor distance by group interaction was not significant 
[F(1,21) = 0.57, p = 0.460]. This non-significant result indicates that both the individuals 
with Parkinson’s disease, and the healthy age-equivalent controls had similar changes in 
conversational speech intensity in response to the change in interlocutor distance. Figure 
6 and 7 suggests that as the interlocutor distance increased, the conversational speech 
intensity levels increased in a similar, parallel manner in both the PD and control groups.   
 The result for the walking condition by group interaction was not significant [F(4, 
18) = 0.09, p = 0.959]. This non-significant result indicates that both the individuals with 
Parkinson’s disease, and the healthy age-equivalent controls had similar changes in 
conversational speech intensity across the five walking tasks.  
 The result for the walking condition by interlocutor distance interaction was 
significant [F(4, 18) = 5.73, p = 0.005] and is illustrated in Figures 6 and 7 with 
associated means and standard deviation scores listed in Tables 9 and 10. This result 
indicates that changes in conversational speech intensity across the five walking 
conditions are different at an interlocutor distance of one meter than six meters for both 
participant groups.  
 
 
 
 
 Table 9. Average Conversational Speech Intensity Across W
One and Six Meter Interlocutor Distance
Sitting 
Standing 
Walking Slow 
Walking Normal 
Walking Fast 
*Note: speech intensity levels are in dB SPL. Standard deviations appear in parentheses beside means.
 
 
Figure 6. Average conversational speech intensity across walking conditions at 
one and six meter interlocutor distance
appear as error bars. 
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67.61 (4.53) 70.36 (3.49)
68.24 (3.25) 70.28 (3.18)
69.79 (3.43) 70.84 (3.40
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 Table 10. Average Conversational Speech Intensity at One and Six Meters 
Interlocutor Distance Across Walking Conditions for Control Participants
Sitting 
Standing 
Walking Slow 
Walking Normal 
Walking Fast 
*Note: speech intensity levels are in dB SPL. Standard deviations appear in parentheses beside means.
  
 
Figure 7. Average conversational speech intensity at one and six meters interlocutor 
distance across walking conditions for control participants
appear as error bars. 
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1 meter 6 meters 
69.76 (2.64) 72.91 (2.21)
69.31 (2.67) 72.25 (2.51)
71.33 (2.52) 74.14 (2.87)
71.85 (2.45) 74.30 (2.48)
73.41 (2.87) 75.73 (3.02)
. Standard deviations 
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The three-way interaction involving the group, interlocutor distance, and walking 
condition was not significant [F(4,18) = 1.65, p = 0.372].  
3.1.3 Post Hoc Comparisons: Walking Conditions, Walking Speeds 
 
In order to examine group differences more closely, a series of post-hoc t-tests 
were conducted using a Bonferonni correction (p=0.05/5 comparisons = .01). The first 
post-hoc analysis examined within-group differences in conversational speech intensity 
across three walking speed conditions. Comparisons were made between walking slow 
and walking fast, walking slow and walking normal, and walking normal and walking 
fast. The results of this analysis are illustrated in Figures 8 and 9, with associated means 
and standard deviations listed in Tables 11 and 12. The detailed results of this post-hoc t-
test related to walking speed and speech intensity are presented in Appendix G. This 
analysis indicates that both the PD and control groups had significantly higher speech 
intensity during the fast walking condition than the normal walking condition when 
participants were at an interlocutor distance of one meter ([t(12) = -3.09, p = .009] and 
[(t(13) = -4.69, p = .000] respectively). At an interlocutor distance of six meters, the 
control group had a significantly higher speech intensity during the fast walking 
condition than the normal walking condition [t(12) = -3.73, p = .003], but the PD group 
did not show a significant difference in conversational speech intensity between the fast 
and normal walking conditions [t(13) = -1.42, p = .177]. The PD and control groups had 
significantly higher conversational speech intensity during the fast walking condition 
than the slow walking condition at an interlocutor distance of one meter ([t(12) = 3.26, p 
= .007] and [t(11) = 4.46, p = .001] respectively). At an interlocutor distance of six 
meters, the control group had a significantly higher speech intensity during the fast 
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walking condition than the slow walking condition [t(13) = 2.95, p = .011], but the PD 
group did not show a significant difference in conversational speech intensity between 
the fast and slow walking conditions [t(13) = 1.59, p = .136]. There was no significant 
difference between the slow walking condition and the normal walking condition for both 
the PD and control groups at an interlocutor distance of one meter ([t(14) = 0.65, p = 
.525] and [t(11) = 1.21, p = .251] respectively) and six meters ([t(13) = -0.11, p = .909] 
and [t(12) = 0.79, p = .447] respectively).  
 
Table 11. Average Conversational Speech Intensity Across Walking Speed 
Conditions for Control Participants 
Walking Condition 
Interlocutor 
Distance Mean (dB SPL) 
Standard 
Deviation 
Walking Slow 1 meter 71.33 2.52 
6 meters 74.17 2.84 
Walking Normal 1 meter 71.85 2.45 
6 meters 74.30 2.48 
Walking Fast 1 meter 73.41 2.87 
6 meters 75.45 2.95 
 
 
 
 Figure 8. Average conversational speech intensity across walking speed conditions 
for control participants. Standard deviations appear as error bars.
 
 
 
 
Table 12. Average Conversational Speech Intensity 
Conditions for PD Participants
Walking 
Condition 
Interlocutor 
Distance
Walking Slow 1
6
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Across Walking Speed 
 
 Mean (dB SPL) Standard Deviation
 meter 67.61 4.60
 meters 70.36 3.49
 meter 67.76 3.25
 meters 70.28 3.18
 meter 69.79 3.42
 meters 71.07 3.4
6-meter
Walking Normal Walking Fast
 
 
 
 
 
 
 
1 
 Figure 9. Average conversational speech intensity across walking speed conditions 
for PD participants. Standard deviations appear as error bars.
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. This analysis indicates that both the 
while standing at an interlocutor distance of one meter 
-7.33, p = .000] respectively) and six meters ([t(12) 
- 5.48, p = .000] respectively). In addition, both the PD 
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at a normal speed than the sitting condition at an interlocutor distance of one meter 
([t(14) = -3.30, p =.005] and [t(13) = -3.71, p = .003] respectively) and six meters ([t(13) 
= -2.95, p = .011] and [t(12) = -3.39, p = .005] respectively). There was no significant 
difference in conversational speech intensity for both the PD and control groups between 
sitting and standing at one meter ([t(13) = 1.68, p = .116] and [t(13) = 0.80, p = .435] 
respectively) and six meters ([t(13) = 0.79, p = .444] and [t(13) = 1.89, p = .080] 
respectively) interlocutor distance.  
 
Table 13. Average Conversational Speech Intensity in Walking versus Not-Walking 
Conditions for Control Participants 
Walking Condition 
Interlocutor 
Distance Mean (dB SPL) Standard Deviation 
Sitting 1 meter 69.76 2.64 
6 meters 72.91 2.30 
Standing 1 meter 69.30 2.68 
6 meters 72.25 2.51 
Walking Normal 1 meter 71.85 2.45 
6 meters 74.30 2.48 
 
 Figure 10. Average conversational speech intensity in walking versus not
conditions for control participants
 
 
 
 
Table 14. Average Conversational Speech Intensity 
Conditions for PD Participants
Walking Condition 
Interlocutor 
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. Standard deviations appear as error bars.
in Walking Versus Not
 
Distance Mean (dB SPL) Standard Deviation
1 meter 65.37 3.58 
6 meters 68.49 3.74 
1 meter 64.24 3.81 
6 meters 68.10 3.58 
1 meter 68.24 3.25 
6 meters 70.28 3.18 
6-meter
Standing Walking Normal
 
-walking 
 
-Walking 
 
 Figure 11. Average conversational speech intensity in walking versus not
conditions for PD participants
 
 
3.2 Conversational Speech Rate 
 
The second primary objective of this study was to examine the effect of 
concurrent walking tasks on conversational speech rate in individuals with Parkinson’s 
disease and healthy age-equivalent controls. A three factor, repeated measures ANOVA 
was performed using participant group as the between groups factor with two levels 
(control, PD). The two within group factors included interlocutor distance and the type of 
walking task. The interlocutor distance factor had two levels (one meter and six meters 
interlocutor distance). The factor related to the type of walking task had five levels 
(concurrent speech + sitting, standing, walking at a speed perceived by the participant to 
be two times slower than their habitual walking speed, walking at a habitual walki
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speed, and walking at a speed perceived by the participant to be two times faster than 
their habitual walking speed). The results of the three-way ANOVA are presented in 
separate sections related to the main effects (group, interlocutor distance, walking 
condition) and the interactions. The results are summarized in Figures 12 and 13 with 
associated means and standard deviations listed in Tables 15 and 16. The results of this 
three-way ANOVA related to speech rate are presented in Appendix H. 
 
Table 15. Average Conversational Speech Rate Across Walking Conditions at an 
Interlocutor Distance of One Meter  
Control PD 
Sitting 229.66 (29.11) 228.29 (38.11) 
Standing 227.01 (23.28) 231.52 (36.31) 
Walking Slow 220.21 (34.14) 230.20 (47.46) 
Walking Normal 228.85 (31.57) 231.19 (38.51) 
Walking Fast 226.58 (20.02) 229.39 (43.31) 
*Note: Speech rate values are in words per minute. Standard deviations appear in parentheses beside means. 
 
 
 Figure 12. Average conversational speech rate across walking conditions at an 
interlocutor distance of one meter
 
 
 
 
Table 16. Average Conversational Speech Rate Across Walking Conditions at an 
Interlocutor Distance of Six Meters
Sitting 
Standing 
Walking Slow 
Walking Normal 
Walking Fast 
*Note: speech rate values are in words per minute
 
125
145
165
185
205
225
245
265
285
Sitting Standing
Sp
ee
ch
 
R
at
e 
(w
o
rd
s 
pe
r 
m
in
u
te
)
47
. Standard deviations appear as error bars.
 
Control PD 
218.21 (23.28) 232.41 (37)
218.89 (38.98) 231.60 (36.93)
222.55 (33.91) 226.65 (41.5)
218.16 (21.61) 239.97 (42.31)
225.31 (23.35) 235.53 (49.81)
. Standard deviations appear in parentheses beside means.
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 Figure 13. Average conversational speech rate across walking conditions at an 
interlocutor distance of six meters
 
 
3.2.1 Main Effects Related to Speech Rate: Group, Interlocutor Distance, and 
Walking Condition 
 The main effect of group was not significant [
illustrated in Figure 14 with associated means and s
non-significant result indicates that there was no overall difference in conversational 
speech rate between participant groups across all interlocutor distance and walking 
conditions.  
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. Standard deviations appear as error bars.
F(1,20) = 0.41, p = 0.530]
tandard error scores in Table 17
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 Table 17. Average Conversational Speech Rate for
Control
223.54
(8.99)
*Note: Speech rate values are in words per minute. 
 
 
Figure 14. Average conversational speech rate for
Standard error scores appear as error bars.
 
 
The main effect of interlocutor distance was not significant [
0.555] and is illustrated in Figure 16 with associated means and standard error scores in 
Table 16. This non-significant result indicates that there was no significant effect
increase in interlocutor distance on conversational speech rate in both participant groups.
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Standard error scores appear in parentheses below means.
 control and PD participants
 
F(1,20) = 0.36, p = 
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 Table 18. Average Conversational Speech Rate at 
Interlocutor Distances 
*Note: Speech rate values are in words per minute.
 
Figure 15. Average conversational speech rate at
distances. Standard error scores
 
 
 
The main effect of walking condition was not significant [
0.820] and is illustrated in Figure 16
Table 19. This non-significant result indicates that th
walking condition on conversational speech rate in both participant groups. 
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1 meter 6 meters 
228.29 226.93 
(6.61) (6.30) 
 Standard error scores appear in parentheses below means.
 the one and six meter interlocutor 
 appear as error bars. 
F(4,17) = 0.4
 with associated means and standard error  scores in 
ere was no significant effect of 
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9, p = 
 Table 19. Average Conversational Speech Rate Across Walking Conditions
Sitting Standing
227.14 227.25
(6.32) (6.53
*Speech rate values are in words per minute. 
 
Figure 16. Average conversational speech rate across walking conditions
error scores appear as error bars.
 
 
 
3.2.2 Interaction Related to Speech Rate: Group, Interlocutor Distance, and 
Walking Conditions 
 The result for the interlocutor distance by group 
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with Parkinson’s disease, and the healthy age
125
145
165
185
205
225
245
Sitting Standing
Sp
ee
ch
 
R
at
e 
(w
o
rd
s 
pe
r 
m
in
u
te
)
51
 Walking Slow Walking Normal Walking Fast
 229.54 229.21 
) (6.71) (6.86) 
Standard errors appear in parentheses below means. 
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conversational speech rate in response to changes in interlocutor distance. While the 
interaction was not significant, it is noted that there was a tendency for the PD 
participants to use a slightly faster speech rate as they went from an interlocutor distance 
of one meter to six meters. On the other hand, there was a tendency for the control 
participants to use a slightly slower speech rate as they went from an interlocutor distance 
of one meter to six meters. 
 The result for walking condition by group interaction was not significant [F(4,17) 
= 0.30, p = 0.960]. This non-significant result indicates that both the individuals with 
Parkinson’s disease, and the healthy age-equivalent controls had similar changes in 
conversational speech rate across the five walking conditions. 
 The result for walking condition by interlocutor distance interaction was not 
significant [F(4,17) = 0.16, p = 0.958]. This non-significant result indicates that changes 
in conversational speech rate across the five walking conditions are similar at both 
interlocutor distances.  
 The three way interaction involving group, interlocutor distance, and walking 
condition was not significant [F(4,17) = 0.46, p = 0.701].  
 
3.3 Walking Speed 
 
The first secondary objective of this study was to examine the effect of concurrent 
talking on walking speed in individuals with Parkinson’s disease and healthy age-
equivalent controls. A three factor, repeated measures ANOVA was performed using 
participant group as the between groups factor with two levels (control and PD). The two 
within group factors included the talking condition and the type of walking task. The 
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factor related to the talking condition had two levels (talking and not-talking). The factor 
related to the type of walking task had three levels (walking at a speed perceived by the 
participant to be two times slower than their habitual walking speed, walking at a habitual 
walking speed, and walking at a speed perceived by the participant to be two times faster 
than their habitual walking speed). The results of the three-way ANOVA are presented in 
separate sections related to the main effects (group, talking condition, and walking 
condition) and the interactions. The results are summarized in Figures 17 and 18, with 
associated means and standard deviations listed in Tables 20 and 21. The detailed results 
of the three-way ANOVA related to walking speed are presented in Appendix I. 
 
Table 20. Average Walking Speed by Walking Condition while Concurrently 
Talking 
Control PD 
Walking Slow 0.83 (0.15) 0.75 (0.19) 
Walking Normal 1.26 (0.19) 0.94 (0.23) 
Walking Fast 1.69 (0.14) 1.24 (0.32) 
*Walking speed values are in meters per second. Standard deviations appear in parenthesis beside means. 
 
 
 Figure 17. Average walking speed by walking condition while concurrently talking
Standard deviations appear as error bars.
 
 
 
 
 
Table 21. Average Walking Sp
Walking Slow
Walking Normal
Walking Fast
*Note: Walking speed values are in meters per second. Standard deviations appear in parenthesis beside means.
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deviations appear as error bars.
 
 
3.3.1 Main Effects Related to Walking Speed: Group, Talking Condition, and 
Walking Conditions 
 The main effect of group was significant [
illustrated in Figure 19 with associated means and s
significant result indicates that there was an overall difference in walking speed between 
participant groups across all of the talking a
participants had an average walking speed that was about 0.3 meters per second slower 
than the control participants (about 19% slower).
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F(1,26) = 15.18, p = 0.001]
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 Table 22. Average Walking Speed for Control and 
*Walking speed values are in meters per second. Standard error values appear in parenthesis below means.
Figure 19. Average walking speed for control and 
scores appear as error bars.
 
 
 
The main effect of talking was also significant [
illustrated in Figure 20 with associated means and s
significant result indicates that 
concurrently talking and walking, than while walking only. 
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Figure 20. Average walking speed while 
walking only. Standard error 
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 all participants walked at their slowest speed in the slow walking condition, and their 
fastest speed in the fast walking condi
 
Table 24. Average Walking Speed Across Walking Speed Conditions for Control 
and PD Participants 
Walking Slow
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*Walking speed values are in meters per second. Standard error 
 
 
Figure 21. Average walking speed across walking conditions for control and PD 
participants. Standard error scores
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(0.03) (0.04) 
scores appear in parenthesis below means.
 appear as error bars. 
Normal Fast
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3.3.2 Interactions Related to Walking Speed: Group, Talking Condition, and 
Walking Conditions 
 The result for the walking condition by group interaction was significant  
[F(2,26) = 15.41, p = 0.000]. This significant result indicates that the PD participants 
changed their walking speed in a manner that was different from the way the control 
participants changed their walking speed. In particular, control participants show 
relatively greater increases in walking speed than the PD group as the intended walking 
speed conditions increased from slow to fast (see Figures 19 and 20, with associated 
means and standard deviations listed in Tables 22 and 23). 
The result for the talking condition by group interaction was not significant 
[F(1,26) = 3.23, p = 0.084]. This non-significant result indicates that concurrent talking 
while walking had a similar effect on walking speed in both participant groups.  
The result for the walking condition by talking condition interaction was 
significant [F(2,25) = 8.82, p = 0.001]. This significant result indicates that some 
walking conditions may be more affected by talking than other walking conditions.  In 
particular, the fast walking condition was associated with a greater difference in walking 
speed between the talking and not talking conditions. In contrast, the slow walking 
condition was associated with a relatively small difference in walking speed across the 
talking and not talking conditions.  
The three way interaction involving group, talking condition, and walking 
condition was not significant [F(2,25) = 0.15, p = .835].  
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A second three factor, repeated measures ANOVA was performed to examine 
whether interlocutor distance had an effect on walking speed in individuals with 
Parkinson’s disease and healthy age-equivalent controls. The participant group was the 
between groups factor with two levels (control and PD). The two within group factors 
included interlocutor distance and the type of walking task. The interlocutor distance 
factor had two levels (one meter and six meters). The factor related to the type of walking 
task had three levels (walking at a speed perceived by the participant to be two times 
slower than their habitual walking speed, walking at a habitual walking speed, and 
walking at a speed perceived by the participant to be two times faster than their habitual 
walking speed). The results of the three-way ANOVA are presented in separate sections 
related to the main effects of interlocutor distance and the interactions. These results are 
summarized in Figures 22 and 23, with associated means and standard deviation scores 
listed in Tables 25 and 26. The detailed results of the three-way ANOVA related to 
walking speed are presented in Appendix J. 
 
Table 25. Average Walking Speed by Walking Condition at an Interlocutor 
Distance of One Meter 
Control PD 
Walking Slow 0.84 (0.15) 0.75 (0.21) 
Walking Normal 1.27 (0.19) 0.95 (0.23) 
Walking Fast 1.71 (0.14) 1.24 (0.35) 
*Note: Walking speed values are in meters per second. Standard deviations appear in parenthesis beside means. 
 
 
 Figure 22. Average walking speed by walking condition at an interlocutor distance 
of one meter. Standard deviations appear as error 
 
 
Table 26. Average Walking Speed by Walking Condition at an Interlocutor 
Distance of Six Meters 
 
 
Walking Slow
Walking Normal
Walking Fast
*Note: Walking speed values are in meters per second. Standard deviations appear in parenthesis beside means.
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bars. 
Control PD 
 0.85 (0.19) 0.722 (0.24) 
 1.24 (0.15) 0.937 (0.28) 
 1.65 (0.13) 1.261 (.37) 
Walking Normal Walking Fast
 
 
Control
PD
 Figure 23. Average walking speed by walking condition at an interlocutor at an 
interlocutor distance of six meters
 
 
3.3.3 Main Effects Related to Walking Speed: Interlocutor Distance
 
 The main effect of interlocutor distance was not significant
[F(1,23) = 0.92, p = .346] and is illustrated in Figure 24
standard errors listed in Table 27
participant groups have similar walking speeds at both interlocutor distances (one meter 
and six meters). 
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. Standard deviations appear as error bars.
 
 
 with associated means and 
. This non-significant result indicates that both 
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PD
 Table 27. Average Walking Speed at 
Meters 
1 meter
(0.0
*Walking speed values are in meters per second. Standard error 
 
Figure 24. Average walking speed at 
Standard error scores appear as error bars.
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an Interlocutor Distance of One and Six 
 6 meters 
1.13 1.11 
4) (0.04) 
scores appear in parenthesis below means.
an interlocutor distance of one and six meters
 
-significant result indicates that an increase in 
6 meters
Interlocutor Distance
 
 
. 
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interlocutor distance does not effect the speed of walking in both participant groups in a 
similar way.  
 The result of the interlocutor distance by walking condition interaction was not 
significant [F(2,22) = 0.02, p = .972].  This non-significant result indicates that the 
changes in walking speed that occurred across the walking speed conditions (slow to fast) 
were similar for the one meter and six meter interlocutor distances. 
The three way interaction involving group, interlocutor distance, and walking 
condition was not significant [F(2,22) = 0.84, p = .538].  
 
 3.4 Stride Length (meters)  
 
The other secondary objective of this study was to examine the effect of 
concurrent talking on average stride length in individuals with Parkinson’s disease and 
healthy age-equivalent controls. A three factor, repeated measures ANOVA was 
performed using participant group as the between groups factor with two levels (control 
and PD). The two within group factors included talking versus not talking and the type of 
walking task. The talking factor had two levels (talking and not-talking). The factor 
related to the type of walking task had three levels (walking at a speed perceived by the 
participant to be two times slower than their habitual walking speed, walking at a habitual 
walking speed, and walking at a speed perceived by the participant to be two times faster 
than their habitual walking speed). The results of the three-way ANOVA are presented in 
separate sections related to the main effects (group, talking versus not-talking, and 
walking condition) and the interactions. The results are summarized in Figures 25 and 26, 
with associated means and standard deviations listed in Tables 28 and 29. The detailed 
 results of the three-way ANOVA related to stride length and concurrent tal
presented in Appendix K. 
 
Table 28. Average Stride Length
Walking Slow
Walking Normal
Walking Fast
*Note: Stride length values are in meters. 
 
 
 
Figure 25. Average stride length by walking condition while concurrently talking
Standard deviations appear as error bars.
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 by Walking Condition while Concurrently Talking
Control PD 
 0.62 (0.07) 0.52 (0.12) 
 0.71 (0.06) 0.58 (0.13) 
 0.83 (0.06) 0.67 (0.15) 
Standard deviations appear in parenthesis beside means.
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 Table 29. Average Stride Len
Walking Slow
Walking Normal
Walking Fast
*Note: Stride length values are in meters. 
Figure 26. Average stride len
deviations appear as error bars.
 
 
3.4.1  Main Effects Related to Stride Length:
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Control PD 
 0.63 (0.08) 0.57 (0.11) 
 0.75 (0.05) 0.65 (0.13) 
 0.85 (0.07) 0.74 (0.11) 
Standard deviations appear in parenthesis beside means.
 
 
 
 
gth by walking condition while not talking. 
 
 Group, Talking Condition, and 
F(1,26) = 15.18, p = 0.001]
tandard error scores in Table 32
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Standard 
 and is 
. This 
between 
Control
PD
 participant groups across all talking versus not
participants had a consistently shorter stride length than the control participants.
 
Table 30. Average Stride Length for Control and 
*Note: Stride length values are in meters. 
 
 
Figure 27. Average stride length for control and P
scores appear as error bars.
 
 
The main effect of the talking condition (i.e. talking versus not talking) was also 
significant [F(1,26) = 39.82, p = 0.000]
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-talking and walking conditions.  The PD 
PD Participants 
PD Control 
0.62 0.73 
(0.02) (0.02) 
Standard error scores appear in parenthesis beside means.
D participants. Standard error 
 
 and is illustrated in Figure 30 with associated 
Control
 
 
 
 means and standard error scores in Ta
length is significantly greater when walking only, than when concurrently talking and 
walking.  
 
Table 31. Average Stride Length While Concurrently Talking and Walking, and 
Walking Only 
Talking
*Note: Stride length values are in meters. 
 
Figure 28. Average stride length while concurrently talking and walking, and 
walking only. Standard deviations appear as error bars.
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ble 33. This significant result indicates that stride 
 Not Talking 
0.66 0.7 
(0.02) (0.02) 
Standard deviations appear in parenthesis beside means..
 
Not Talking
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 The main effect of walking condition was also significant
[F(2,25) = 88.58, p = 0.000] 
standard error scores listed in Table 34
participant groups had significant differences in stride length across the three walking 
conditions. For example, both participant groups showed an increa
they shifted from the slow walking condition to the fast walking condition. 
 
Table 32. Average Stride Length Across Walking Speed Conditions
Slow 
0.58 
(0.02) 
*Note: Stride length values are in meters. 
 
Figure 29. Average stride length across walking speed conditions
deviations appear as error bars.
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Standard deviations appear in parenthesis beside means.
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3.4.2  Interactions Related to Stride Length: Group, Talking Condition, and 
Walking Condition 
The result for the walking condition by group interaction was not significant  
[F(2,25) = 1.26, p = 0.118]. This non-significant result indicates that the PD and controls 
groups had similar changes in stride length across all walking conditions.  
The result for the talking condition by group interaction was significant [F(1,26) 
= 6.58, p = 0.016]. This significant result indicates that concurrent talking while walking 
had a different effect on stride length in the PD group than the control group.  In 
particular, the PD group showed a relatively greater reduction in stride length than that of 
the controls when they shifted from the not talking to the talking condition.  
The result for the walking condition by talking condition interaction was not 
significant [F(2,25) = 2.67, p = 0.131]. This non-significant result indicates that talking 
and not talking had similar effects on stride length across all walking conditions.  
The three way interaction involving group, talking versus not talking, and walking 
condition was not significant [F(2,25) = 2.67, p = .088].  
 
A second three factor, repeated measures ANOVA was performed to examine 
whether interlocutor distance had an effect on stride length in individuals with 
Parkinson’s disease and healthy age-matched controls. The participant group was the 
between groups factor with two levels (control and PD). The two within group factors 
included interlocutor distance and the type of walking task. The interlocutor distance 
factor had two levels (1-meter and 6-meters). The factor related to the type of walking 
task had three levels (walking at a speed perceived by the participant to be two times 
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slower than their habitual walking speed, walking at a habitual walking speed, and 
walking at a speed perceived by the participant to be two times faster than their habitual 
walking speed). The results of the three-way ANOVA are presented in separate sections 
related to the main effects of interlocutor distance and the interactions. The results are 
summarized in Figures 27 and 28, with associated means and standard deviations listed in 
Tables 30 and 31. The detailed results of the three-way ANOVA related to stride length 
and interlocutor distance are presented in Appendix L. 
 
Table 33. Average Stride Length by Walking Condition at an Interlocutor Distance 
of One Meter  
Control PD 
Walking Slow 0.62 (0.07) 0.52 (0.13) 
Walking Normal 0.70 (0.06) 0.59 (0.14) 
Walking Fast 0.83 (0.06) 0.68 (0.16) 
*Note: Stride length values are in meters. Standard deviations appear in parenthesis beside means. 
 
 
 
 Figure 30. Average stride length by walking condition at 
one meter. Standard deviations appear as error bars.
 
 
 
Table 34. Average Stride Length by Walking Condition at 
of Six Meters 
Walking Slow
Walking Normal
Walking Fast
*Note: Stride length values are in meters. 
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an interlocutor distance of 
 
an Interlocutor Distance 
Control PD 
 0.61 (0.06) 0.51 (0.14) 
 0.71 (0.05) 0.59 (0.14) 
 0.80 (0.08) 0.69 (0.18) 
Standard deviations appear in parenthesis beside means.
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 Figure 31. Average stride length by walking condition at 
six meters. Standard deviations appear as error bars. 
 
3.5 Reliability 
 
  To determine the 
conversational speech intensity and speech rate measures
stride length measures, the original judge re
was analyzed by a second judge. A bivariate correlation analysis revealed high intra
judge reliability for all measures, with correlation coefficients ranging from .86 
analysis also revealed high inte
coefficients ranging from .84 
analysis used to obtain inter and intra
demonstrates good overall reliability between and within judges for conversational 
speech intensity, conversational speech rate, walking speed, and stride length measures. 
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inter-judge and intra-judge reliability of the 
, and the walking speed and 
analyzed 10% of the data and 10% of the data 
r-judge reliability for all measures, with correlation 
- .99. Table 35 summarizes the results of the correlation 
-judge reliability estimates. This correlation analysis 
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-
- .99. The 
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Table 35. Inter and Intra-Judge Reliability 
Pearson Correlation Coefficients 
 Intra-Judge Inter-Judge 
Conversational Speech 
Intensity (dB) 
.94, p = .00 .95, p = .00 
Conversational Speech Rate 
(WPM) 
.89, p = .00 .84, p = .00 
Walking Speed (m/s) .86, p = .00 .99, p = .00 
Stride Length (m) .99, p = .00 .99, p = .00 
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Chapter 4 
 
4 Discussion 
 
The goal of the present study was to examine the effect of concurrent walking 
tasks and interlocutor distance on conversational speech intensity and conversational 
speech rate in individuals with PD and controls. The main objectives of this study were 
to: 1) examine the effects of concurrent walking on conversational speech intensity and 
conversational speech rate; 2) examine the effects of interlocutor distance on 
conversational speech intensity and conversational speech rate; 3) examine the effects of 
concurrent talking on walking speed; 4) examine the effects of concurrent talking on 
stride length. The following sections will discuss the findings of the present study and 
relate these findings to previous research examining the effect of concurrent tasks on 
conversational speech intensity and speech rate, interlocutor distance, and concurrent task 
effects on walking performance. The limitations of the present study will also be 
discussed, along with clinical implications and recommendations for future research.  
 
4.1  Effect of Concurrent Walking Tasks and Interlocutor Distance on 
Conversational Speech Intensity 
Conversational intensity of Parkinson’s and control groups. The results of this 
study revealed a significant difference in conversational speech intensity values between 
the Parkinson and control groups. Individuals with PD produced a conversational speech 
intensity that was on average 4 dB lower than that of the control participants. In the 
current study, conversational speech intensity varied across walking conditions and 
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interlocutor distance conditions, but the difference between PD and control participants 
remained consistently around 2-4 dB SPL.  A 2-4 dB SPL change in intensity is equal to 
about a 40% reduction in perceived loudness (Fox & Ramig, 1997). This finding is in 
agreement with several previous studies that have reported that individuals with PD have 
conversational speech intensity levels that are 2-4 dB SPL lower than those of healthy 
age-equivalent controls (Fox & Ramig, 1997; Ho et al., 1999; Adams et al., 2010).  
Low speech intensity (hypophonia) is generally recognized as one of the 
distinctive speech symptoms of PD. It is estimated that 40-50% of individuals with 
hypokinetic dysarthria will present with low speech intensity, and it is often the first 
speech symptom to become apparent in the early stages of the disease (Adams et al., 
2010). 
 
Effect of interlocutor distance on conversational intensity in Parkinson’s and 
control groups. The results of this study revealed a significant difference in 
conversational speech intensity values between the one-meter and six-meters interlocutor 
distances for both the PD and control participants. Both participant groups significantly 
increased their conversational speech intensity in response to the increase in interlocutor 
distance. The PD and control participants were on average 2.5 dB louder at an 
interlocutor distance of six-meters than one-meter. This is in agreement with Ho et al. 
(2002) and Adams et al. (2010) who found that both PD and control participants 
increased their speech volume to compensate for an increase in interlocutor distance. In 
addition, there was no significant interaction between groups at one-meter and six-
meters. This finding that individuals with PD demonstrate a normal pattern of intensity 
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regulation relative to controls in response to increased interlocutor distance is consistent 
with previous studies (Ho et al., 1999; Adams et al., 2010).  
 
Effect of walking conditions on conversational speech intensity in 
Parkinson’s and control groups. The results of this study revealed a significant 
difference in conversational speech intensity values between walking conditions for both 
the PD and control participants. Post hoc analyses revealed that individuals with PD and 
control participants had significantly greater conversational speech intensity during 
walking conditions relative to the sitting and standing conditions. In addition, walking 
fast was associated with the greatest increase in conversational speech intensity for both 
participant groups at one-meter interlocutor distance. 
Several hypotheses were considered in relation to the effect of concurrent tasks on 
conversational speech intensity. The results of the present study appear to provide 
support for the energizing hypothesis. The energizing hypothesis proposes that there is an 
energizing effect on conversational speech intensity when speech is performed 
concurrently with other tasks. This energizing effect is proposed to cause speech intensity 
to increase during concurrent motor tasks such as walking, manual actions and other 
motor behaviours (Adams et al., 2010).  
The findings of the present study are in agreement with the Adams et al. (2010) 
study, which found an increase in speech intensity in individuals with PD during a 
concurrent manual visuomotor tracking task. In addition, the results of this study are in 
agreement with the Dromey and Shim (2008) study, and the Dromey and Bates (2005) 
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study that found an increase in speech intensity during concurrent manual tasks in young 
healthy participants.  
In contrast to these findings, other studies have demonstrated a reduction in 
speech intensity while performing a secondary task. The control participants in the 
Adams et al. (2010) study demonstrated a reduction in speech intensity while performing 
a concurrent manual visuomotor tracking task. It was suggested that this failure to 
observe an energizing effect might have been related to the relatively easy nature of the 
concurrent manual task for the control participants. Adams et al. (2010) proposed that the 
energizing effect of concurrent tasks on speech intensity may be dependent on the 
difficulty level of the concurrent task. Interestingly, in the present study the walking 
condition by group interaction was not significant. This result indicates that both 
participant groups were affected by the walking tasks in a similar way. Both the PD and 
control groups had significantly greater conversational speech intensity while walking 
than while sitting or standing. In addition, both groups demonstrated a similar increase in 
conversational speech intensity across walking conditions. Both participant groups 
demonstrated a 2-5 dB increase in conversational speech intensity when they shifted from 
sitting to walking. This suggests that the concurrent walking task was sufficiently 
complex or challenging enough to produce an energizing effect on the conversational 
speech intensity of both the PD and control participants. 
One additional study that failed to demonstrate an energizing effect of a 
concurrent task on speech intensity was the study by Ho et al. (2002). This study found 
that when individuals with PD produced a loud speech task involving loud counting of 
numbers there was a significant decrease in the speech intensity.  This result suggests that 
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the energizing effect of a concurrent task on speech intensity may not extend to 
conditions of high intensity speech production. Perhaps there is a ceiling effect that does 
not allow for increases in speech intensity when speech is already being produced at a 
high level of intensity. 
Although the results of the present study appear to provide support for the 
energizing hypothesis, additional studies that involve the systematic examination of 
different speech tasks and the careful evaluation of various concurrent task parameters 
are required in future studies. 
 
Effect of walking speed on conversational speech intensity in Parkinson’s 
and control groups. In general, the speed of walking was found to have an effect on 
conversational speech intensity. The post-hoc analyses revealed that both PD and control 
participants had significantly greater speech intensity while walking fast than while 
walking at a comfortable speed or walking slow at one meter interlocutor distance. 
In the Dromey and Shim (2008) study and the Dromey and Bates (2005) study, 
the authors proposed that greater speech intensity may be the result of an overall increase 
in effort caused by the introduction of a concurrent task. The results of this study are 
consistent with this hypothesis, suggesting that an increase in effort (by walking faster) in 
one task translates to increased effort (greater speech intensity) in the other task.  
This is the first study to provide evidence that increasing physical effort in a 
highly pre-programmed functional task, such as walking, increases conversational speech 
intensity in individuals with PD. This result suggests that physical effort as well as task 
complexity may play a role in the energizing effect of concurrent tasks on speech 
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intensity. Further research should investigate the interaction between lower limb 
activities and motor speech acoustics, as well as the effect of increased physical effort of 
dual-task activities on motor speech acoustics.   
 
Effect of standing on conversational speed intensity in Parkinson’s and 
control groups. The results of this study revealed no significant difference in 
conversational speech intensity between sitting and standing for both PD and control 
participants. However, both the PD and control participants demonstrated a slight 
reduction in conversational speech intensity (0.5 dB and 1.5 dB respectively) when 
standing, compared to sitting.  
It was hypothesized that standing would enhance speech intensity by pre-
activating or exciting the motor cortex. This hypothesis was based on the Meinzer et al. 
(2011) study that reported an enhancing effect of standing on word retrieval performance 
in individuals with aphasia. The authors suggested that pre-activation of the motor cortex 
could be used to excite the language network. In the present study it was hypothesized 
that standing may have a similar excitatory effect on the speech production system. 
Interestingly, the results of the present study did not show an excitatory effect of standing 
on the speech production parameter of speech intensity. Future studies are required to 
determine if there are excitatory effects of standing on other parameters of speech 
production (i.e., speech fluency, voice quality).  
Holmes et al. (2010) investigated concurrent interference on postural control and 
proposed that individuals with PD and healthy older adults employ a ‘posture-first 
principle’ under dual-task conditions. This principle suggests that people prioritize 
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balance over concurrent tasks, and this prioritization becomes more pronounced with 
high complexity tasks, such as talking. It is possible that both participant groups attended 
more to balance and postural stability than to motor speech performance.  However, if 
this prioritization of balance caused interference in motor speech performance, it would 
be expected that the reduction in speech intensity would be exacerbated while walking, 
especially in the fast walking condition. O’Shea et al. (2002) stated that fast walking 
speeds require greater balance control because of the rapidly changing accelerations of 
the center of mass and the reduction in double support time. Therefore, it is possible that 
an overall increase in physical effort, by walking, has a more powerful effect on motor 
speech performance than the posture-first strategy.  
In general, the results of the present study indicate that concurrent walking tasks 
can have a significant effect on conversational speech intensity. These effects need to be 
given consideration in future attempts to develop a comprehensive model of speech 
intensity regulation and in future attempts to understand the problem of hypophonia in 
PD. 
 
4.2  Effect of Concurrent Walking Tasks and Interlocutor Distance on 
Conversational Speech Rate 
 Conversational speech rate of Parkinson’s and control groups. The results of 
this study revealed no significant difference in conversational speech rate between the PD 
and control participants. The results of this study are in agreement with previous studies, 
which found no significant difference in the speaking rate between individuals with PD 
and healthy adults (Flint et al., 1992; Walsh & Smith, 2012; Tjaden & Wilding, 2011).  
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Previous studies have shown that typical discourse speaking rates for healthy adults is 
between 143 and 183 WPM (words per minute) or 195 and 236 SPM (syllables per 
minute). In contrast, the mean conversational speech rate for the control participants in 
the present study was 223.5 WPM, which is slightly faster than previous reports.  
A few previous studies have suggested that only a small proportion of individuals 
with PD (6-13%) demonstrate an abnormally rapid speech rate (Adams & Dykstra, 2009), 
however most previous studies have found that speech rate in PD is comparable to that of 
age-equivalent controls (Adams & Dykstra, 2009).  
  It should be noted that one recent study by Tjaden and Wilding (2011) reported no 
significant difference between PD and control participants for speech rate but a 
significant difference for pause durations. PD participants had significantly longer pause 
durations than controls. This study by Tjaden and Wilding (2011) involved speech during 
a reading aloud task. Additional research is required to determine the characteristics of 
pause durations in PD speakers during conversational speech. 
 
Effect of interlocutor distance on conversational speech rate in Parkinson’s 
and control groups. The results of this study revealed no significant difference in 
conversational speech rate at the one-meter and six-meters interlocutor distances for both 
the PD and control groups. This may suggest that the mechanisms involved in increasing 
speech volume do not effect speaking rate. This result was somewhat unexpected. 
Previous studies have found that loud speech can be associated with a reduction in speech 
rate (Wenke, Theodoros, & Cornwell, 2011; Schulman, 1989). Thus, it is somewhat 
surprising that the increased speech intensity associated with greater interlocutor distance 
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did not produce a corresponding reduction in speech rate in the present study. It should be 
noted that there was a tendency for the control participants to use a slightly slower speech 
rate as they increased their interlocutor distance from one to six meters. In contrast to 
this, the PD participants showed a tendency to increase their rate of speech as the 
interlocutor distance increased.  Additional studies are required to investigate the 
relationship between speech intensity and speech rate in both PD and control participants.  
These future studies should examine the effect of a wide range of changes in speech 
intensity on speech rate. The present study was associated with significant changes in 
speech intensity (+2dB) however larger changes in speech intensity may be necessary in 
order to observe significant effects on speech rate. 
 
 Effect of walking condition on conversational speech rate in Parkinson’s and 
control groups. In general, the results of this study revealed no significant difference in 
conversational speech rate between the five walking conditions. In addition, there was no 
significant difference between groups across the five walking conditions. The present 
study is in agreement with the finding by Ho et al. (2002) that control participants had no 
significant change in speech rate while performing concurrent manual tracking task. The 
present study is also in agreement with a study by Pohl, Kemper, Siengsukon, Boyd, and 
Vidoni (2011) that looked at the effect of walking on conversational speech rate in older 
adults with and without a stroke. For both of these participant groups, Pohl et al. (2011) 
found no significant difference in the conversational speech rate between the walking and 
not walking conditions. In contrast, Kemper, Herman, and Lian (2003) investigated 
conversational speech rate in healthy older adults and found a significant reduction in 
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conversation speech rate while performing concurrent finger tapping or walking tasks. 
The inconsistencies in speaking rate for both healthy control participants and individuals 
with PD may be partially explained by methodological differences across these 
concurrent speech studies. Both the Ho et al. (2002) and Kemper et al. (2003) studies 
used concurrent manual tasks. On the other hand, the Pohl et al. (2011) study used a 
concurrent walking task and they elicited conversational speech using a methodology that 
was very similar to that of the present study. The Pohl et al. (2011) and the present study 
failed to show an effect of concurrent walking on speech rate. Additional studies are 
required to compare the effects of concurrent walking tasks versus concurrent manual 
tasks on speech rate and other aspects of speech production.  
 
4.3  Effect of Concurrent Talking, Interlocutor Distance and Walking 
Condition on Walking Speed 
 Walking speed of Parkinson’s and control groups. The results of this study 
revealed that the PD participants walked significantly slower than the control participants 
across all of the talking and not-talking walking conditions. This finding is in agreement 
with previous studies that suggest that gait impairments are a common consequence in 
PD, and reduced gait velocity is one of the most distinctive gait impairments (Rochester 
et al., 2005; O’Shea et al., 2002; Morris et al., 1994b; Mak, 2013). In the present study, 
the mean gait velocity of the control participants was 1.27 meters per second, which is in 
agreement with a number of previous studies that suggest habitual walking speed is 
between 0.88 and 1.36 meters per second (Rochester et al., 2005; O’Shea et al., 2002; 
Morris et al., 1994b; Mak, 2013). In contrast, the PD participants in the present study 
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walked at a mean gait velocity of 0.95 meters per second, which is slightly faster than 
previously reported for individuals with PD (0.56 - 0.83 meters per second [Rochester et 
al., 2005; O’Shea et al., 2002; Morris et al., 1994b; Mak, 2013]). 
 It is also interesting to note that both participant groups did not actually produce a 
two times faster or two times slower walking speed in the particular walking speed 
conditions. For example, when the participants were asked to walk two times faster than 
their normal walking speed (1.2 m/s) they only increased their walking speed by about 
33% (+0.4 m/s) instead producing a doubling or a 100% increase in their walking speed 
(2 * 1.2 = 2.4 m/s).  The psychophysical relationship between the perceived and actual 
magnitude of a stimulus has been described for many types of physical stimuli (Stevens, 
1962; Grosjean & Lane, 1973). In many previous psychophysical studies, the perceived 
magnitude of a self-generated activity or movement has been found to be exponentially (a 
power function) related to the actual magnitude of the physical stimulus (Stevens, 1962).  
In speech production, this psychophysical relationship is referred to as an autophonic 
function. Autophonic functions have been described for speech intensity/loudness and 
speech rate (Lane, Catania & Stevens, 1961; Grosjean & Lane, 1973).  For speech rate, 
an autophonic power function of 2.6 has been determined (Grosjean & Lane, 1973). This 
power function is the linear function that was obtained from a log-log plot of perceived 
and actual speech rate. This function (2.6) means that in order for a person to actually 
produce a rate of speech that is two times faster they would need to have the perception 
that they are producing a rate of speech that is six times faster. A function that is similar 
to this six-fold relationship appears to be present for the walking speed results that were 
obtained in the present study. When the participants were asked to double their walking 
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speed they only increased their walking speed by about 33%. Thus, it appears that the 
participants would need to be asked to try to walk at approximately six times their normal 
walking speed in order for them to produce a walking speed that was actually two times 
faster than their normal speed. This perceived-to-actual psychophysical function for 
walking speed needs to be further investigated and defined in future studies. 
 
 Effect of interlocutor distance on walking speed in Parkinson’s and control 
groups. The results of this study revealed no significant difference in walking speed at 
one-meter and six-meters interlocutor distance. This result suggests that the mechanism 
involved in increasing vocal output appears to have little or no effect on walking speed. 
Additional concurrent walking and talking studies that involve greater increases in speech 
intensity (+ 2dB) are required to examine this proposed null relationship in greater detail.  
  
 Effect of changing walking speed in Parkinson’s and control groups. The 
results of this study revealed that walking speed was significantly different across the 
three walking speed conditions. Both participant groups walked significantly slower in 
the slow walking condition, and significantly faster in the fast walking condition.  
In the fast walking condition, the PD participants were walking at a speed relative 
to the control participant’s normal walking speed. In the walking only condition the fast 
walking speed for the PD participants was 1.24 meters per second, and the normal 
walking speed of the control participants was 1.26 meters per second. The same 
relationship was found while concurrently talking. The fast walking speed for the PD 
participants was 1.46 meters per second, and normal walking speed of the control 
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participants was 1.41 meters per second.   A study by Morris et al. (1994b) had similar 
findings, and suggested that individuals with PD have the capacity to walk at the normal 
speed for age-equivalent controls, but walking speed is habitually reduced because stride 
length is shortened. When individuals with PD are asked to walk at faster speeds, their 
stride length approximates the stride lengths of the healthy age-equivalent controls 
walking at a normal speed. In addition, the previous studies investigating walking speed 
have incorporated stride length cues, or have used pre-determined walking speeds on a 
treadmill to demonstrate that PD participants have the capacity to walk at the normal 
speed of healthy age-equivalent participants. This study reveals that when simply asked 
to walk faster, without the additional assistance of stride length cues, the PD participants 
selected a fast walking speed that approximates the normal walking speed of healthy age-
equivalent controls. This finding was replicated during the concurrent talking condition.   
 The interaction between the walking speed conditions and the participant group 
was significant. This result reveals that the PD group and the control group regulated 
walking speed differently across walking speed conditions. A potential explanation this 
significant interaction may be because the PD group had a more limited range in walking 
speed than the control group. From the slow to fast walking speed conditions, the control 
group had a range from 0.85 meters per second to 1.84 meters per second, whereas the 
PD participants had a range from 0.86 meters per second to 1.46 meters per second. It 
appears that although the PD participants can walk at speeds relative to the habitual speed 
of the control group, they may not have the capacity to walk at the fast speed of the 
control group. A potentially useful method of evaluating the capacity of the PD 
participants would be to ask them to walk at their maximum speed in future studies.  This 
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task was given consideration in the planning of the present study but the risk of falls in 
the PD participants was a major concern. Future studies involving maximum walking 
speed in PD participants may need to consider the use of a support harness or other 
device to minimize the risk of falls.  
 The more restricted range of walking speeds of the PD participants also suggests 
that the psychophysical relationship related to the perceptual scaling of walking speed 
may be abnormal in the PD participants. Additional studies, involving the systematic 
perceptual scaling of a wide range of walking speeds, are required to investigate the 
psychophysical relationship related to the perception of walking speed in PD.  
 Of potential importance for future studies involving the perception of walking in 
PD, were the frequent verbal reports by the PD participants who found that the slow 
walking condition was the most difficult walking condition in the present study. It may 
be important to examine the perception of walking difficulty or the perception of walking 
effort in future studies of walking speed in PD.  
 
 Effect of concurrent talking on walking speed. The results of this study 
revealed that both participant groups walked significantly slower while talking, than 
while walking only. This is in agreement with a number of studies that have found that 
talking significantly effects walking performance (Morris et al., 1996; O’Shea et al., 
2002; Bloem et al., 2004; Rochester et al., 2008; Kelly et al., 2012). A substantial amount 
of research has been dedicated to investigating the effects of concurrent tasks on walking 
performance because individuals with PD are considered to be at an increased risk for 
falls during concurrent activities (Bloem et al., 2004; Morris et al., 1996). The results of 
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these studies provide consistent evidence that talking (or performing other types of 
concurrent tasks) significantly deteriorates walking performance (Galletly & Brauer, 
2005; O’Shea et al., 2002; Rochester et al., 2004; Morris et al., 1996; Bloem et al., 2004).  
 Of additional interest was the finding of a relatively similar (negative) effect of 
talking on the walking speed of the PD and control participants.  This was supported by 
the failure to find a significant group by talking condition interaction for the measure of 
walking speed.  However, the results demonstrate that the PD participants experienced a 
greater reduction in walking speed than the control participants, although the interaction 
did not reach statistical significance. The control participants experienced an 11% 
reduction in walking speed while concurrently talking compared to walking only, while 
the PD participants experienced an 18% reduction in walking speed. A similar result was 
obtained in a previous study by O’Shea et al. (2002), which found that both PD and 
control participants experienced a greater reduction in walking speed when they were 
engaged in concurrent talking and walking (O’Shea, et al. 2002). This is in agreement 
with a number of studies that suggest that individuals with basal ganglia dysfunction have 
greater difficulty coping with concurrent tasks, resulting in a greater reduction of walking 
speed and stride length relative to control participants (Rochester et al., 2008; O’Shea et 
al., 2002; Kelly et al., 2012).  
 
4.4  Effect of Concurrent Talking, Interlocutor Distance and Walking 
Condition on Stride Length 
Stride length of Parkinson’s and control groups. The results of this study 
revealed that individuals with PD had a significantly shorter stride length than the control 
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participants across all concurrent talking conditions and walking speed conditions. This 
result is consistent with a number of studies suggesting that walking performance is 
impaired in individuals with PD, and one of the fundamental problems in gait 
hypokinesia in PD is shortened stride length (Morris et al., 1996). The mean stride length 
for PD and control participants in the present study was 0.65 and 0.75 meters, 
respectively. Previous studies suggest that mean stride length values are between 1.24 
and 1.47 meters for healthy controls, and 0.75 and 0.92 meters for PD participants. 
Interestingly, both participant groups in the present study had stride lengths that were 
shorter than ‘typical’ values previously reported in the literature. 
 
Effect of concurrent talking on stride length. The results of this study revealed 
that both participant groups had a significantly shorter stride length while concurrently 
talking and walking. This is consistent with a number of studies investigating concurrent 
task effects on walking performance (see Kelly et al. (2012) for review), that found that 
stride length is significantly shorter while engaged in concurrent tasks for both PD and 
healthy age-equivalent controls. In the present study, the control participants had a stride 
length of 0.75 meters while walking and not talking at their normal comfortable speed. 
When engaged in a concurrent task, their stride length reduced by approximately 5% to 
0.71 meters. In the normal walking and not talking condition, the PD participants had a 
stride length of 0.65 meters, which reduced by approximately 11% to 0.58 meters while 
concurrently talking. A similar pattern of results was found for the fast and slow walking 
condition. Thus, there was a significant reduction in walking stride length when the 
participants were talking and walking relative to when they were walking and not talking. 
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Thus, the PD participants demonstrated a relatively greater reduction in stride length than 
the control participants when they shifted from the walking and not talking conditions to 
the walking and talking conditions. This was confirmed by the significant interaction for 
group by talking condition for stride length. This is in agreement with a number of 
previous studies that have demonstrated greater reductions in stride length in PD 
participants (approximately 14%) than control participants (approximately 4%) while 
engaged in concurrent task conditions (O’Shea et al., 2002; Rochester et al., 2008; Kelly 
et al., 2012).  
 
Effect of changing walking speed on stride length. The results of this study 
revealed that walking speed significantly impacted stride length. Both the PD and control 
participants experienced longer stride lengths while walking fast, and the shortest while 
walking slow.  
Both participants demonstrated a systematic increase in stride length as the 
walking speed increased. In the walking only condition the stride length of the control 
participants went from 0.63 meters to 0.75 meters to 0.85 meters (slow, normal, and fast 
walking conditions respectively). A similar relationship was found in the PD group, as 
their stride length went from 0.57 meters to 0.65 meters to 0.74 meters (slow, normal, and 
fast walking conditions respectively). At baseline, the PD participants have a smaller 
stride length, and this overall reduction remains across all walking speed conditions. In 
agreement with these findings, Morris et al. (1996) found that as walking speed increases, 
step size increases for both PD and control participants.   
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In a previous study by Morris et al. (1994a b), they found that when gait velocity 
is controlled, the walking cadence is higher and stride length is shorter in individuals with 
PD than in healthy age-matched controls. 
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Chapter 5 
 
5.1 Strengths and Limitations 
 
Strengths. Previous dual-task studies investigating speech parameters in PD have 
employed simple upper-limb motor tasks (finger-tapping, motor tracking), but it is 
difficult to generalize these findings to other types of behaviors or motor tasks. The 
present study investigated conversational speech intensity and rate in a more ecologically 
valid context than has been previously studied (talking while walking), and is the first to 
examine the effect of lower-limb concurrent tasks on these speech acoustic measures.   
Limitations. The first limitation of the present study involves the unequal number 
of male and female PD participants.  Although there were an equal number of male and 
female control participants (7 male, 7 female), the PD group had 2 female and 13 male 
participants. The gender differences may have influenced the conversational speech 
intensity results, as gender differences have been previously reported in studies 
investigating the effect of interlocutor distance on speech intensity. For example, Healey, 
Jones, and Berky (1997) found that during a reading aloud speech task, young women 
demonstrated greater increase in speech intensity in response to changes in interlocutor 
distance than young men. However, it should be noted that the young women in the 
Healey et al. (1997) study had an atypically low average speech intensity of 62 dB 
(calibrated at 15cm) at an interlocutor distance of 3 feet. On the other hand, the young 
men had a more typical average speech intensity (74dB) that was 12 dB higher than that 
of the young women. Additional studies are required to replicate the Healey et al. (1997) 
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study and to determine if there is a gender difference for the effect of interlocutor 
distance on conversational speech intensity in both young and older adults. 
Another possible methodological limitation of the present study was that all of the 
walking conditions were performed during one 30-60 minute session. Participants moved 
through the walking conditions in a randomized order, which occasionally required 5-10 
minutes of continuous walking at various walking speeds. Although all participants were 
encouraged to take occasional rests between walking speed conditions, participants may 
have become tired near the end of the experimental protocol. Fatigue may have 
influenced walking speed and stride length values in conditions at the end of the 
experimental protocol.  
 It should also be noted that the gait measurement methodology was not as refined 
or detailed as that of other gait-focused studies of PD. Many of these previous gait studies 
have used highly specialized kinematic and kinetic instrumentation. The present study 
used a fairly simple video methodology to obtain some potentially important findings 
related to the effect of conversational speech on gait but additional instrumental studies 
are required to confirm these findings and to provide a more comprehensive description 
of these effects on gait performance in PD. 
 A final potential limitation relates to the ecological validity of the conversational 
speech and walking tasks. The intention of the present study was to examine the 
concurrent effects of walking and talking in PD in a fairly natural or ecologically valid 
context. With this in mind, a conversational speech task was selected to represent a fairly 
typical speech activity and walking in a common gymnasium was selected to represent a 
fairly typical walking context. However, it is possible to imagine a walking and talking 
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study with potentially greater ecological validity.  For example, the speech task could 
involve typical conversations with a person who regularly talks with the participant (i.e. 
spouse). Likewise, the walking context could involve locations where the participant 
would typically go for walks (i.e. neighborhood street, local walking path, or shopping 
mall).  Unfortunately, some of these contexts with potentially greater ecological validity 
are associated with significant methodological challenges. These include difficulty 
controlling the level of background noise during the speech recordings and the limited 
availability of gait measurement systems that can be used in a variety of naturalistic 
environments. Additional instrumental development is required to solve many of these 
methodological challenges.  
 
5.2 Future Directions 
 
The current study provides a novel perspective with regard to how concurrent 
tasks can effect conversational speech intensity in individuals with PD. Previous studies 
have shown support for an energizing effect on speech intensity while performing 
concurrent upper-limb activities, such as finger-tapping or visuomotor manual tasks 
(Dromey & Bates, 2005; Dromey & Shim, 2008; Adams et al., 2010). The present study 
demonstrated an energizing effect of lower-limb activities on conversational speech 
intensity in PD and control participants. Future research involving the careful evaluation 
of various concurrent task parameters should be performed to further investigate and 
define the energizing effect of secondary tasks on speech intensity and other speech task 
parameters. In addition, the finding that faster walking speeds can produce significantly 
greater conversational speech intensity needs further investigation. Future studies should 
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examine the effect of increased physical effort during dual-task activities (upper and 
lower-limb) on speech intensity and other aspects of speech performance.   
In addition, the results of the present study demonstrated that both participant 
groups did not actually produce a two times faster or slower walking speed in the targeted 
walking speed conditions. A psychophysical relationship between the perceived and 
actual magnitude of an activity or movement has been previously reported in studies 
investigating speech intensity and rate (referred to as autophonic function). The present 
study reveals that this psychophysical relationship appears to exist across many 
modalities. Additional studies, involving the systematic perceptual scaling of a wide 
range of walking speeds, are required to investigate the psychophysical relationship 
related to the perception of walking speed in PD.  
Future studies should investigate the relationship between speech intensity and 
speech rate in both PD and control participants. Although the present study found no 
significant difference in speech rate between participant groups, a wider range of changes 
in speech intensity (greater than 2 dB) may be necessary to observe significant effects on 
speech rate.  
 
5.3 Clinical Implications 
 
The effect of concurrent walking on conversational speech intensity needs to be 
given consideration in future attempts to develop a comprehensive model of speech 
intensity regulation and in future attempts to understand the problem of hypophonia in 
PD. In addition, the finding that fast walking causes a greater increase in conversational 
speech intensity than walking at a comfortable speed may have important implications for 
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speech therapy treatments that incorporate physical activities. For example, intensive 
phonatory-respiratory voice treatments for individuals with PD, such as the Lee 
Silverman Voice Treatment (Ramig, Sapir, Fox, & Countryman, 2001) should consider 
incorporating activities that are physically challenging in a supervised environment to 
promote increased speech intensity.   
In addition, Speech and Language Pathologists should consider assessing and 
treating individuals with PD in their natural communication environments since the 
variables used in the present study were chosen to mimic these natural contexts and were 
found to have significant effects on speech intensity.  These natural communicative 
environments could include at home assessments, walking through a building, walking 
outside, or other locations that the patient frequently attends.  
 
5.4 Summary and Conclusions 
 
The primary objectives of the present study were to examine the effect of 
concurrent walking and interlocutor distance on conversational speech intensity and 
speech rate in 15 individuals with Parkinson’s disease and 14 age-equivalent controls. 
The walking conditions included (1) sitting, (2) standing, (3) walking at a comfortable 
speed, (4) walking at a speed perceived by the participant to be two times slower than 
their comfortable walking speed, and (5) walking at a speed perceived by the participant 
to be two times faster than their comfortable walking speed. The walking conditions were 
performed over two interlocutor distances: 1-meter and 6-meters. 
The conversational speech intensity results demonstrated that the average 
intensity of the PD participants across all walking and talking conditions was 
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approximately 4 dB lower than the control participants. This result provides confirmation 
of hypophonia in the PD participants. All of the concurrent walking speed conditions 
were associated with increased speech intensity relative to the sitting condition. The 
fastest walking speed condition was associated with the greatest increase in 
conversational speech intensity for both the participant groups. Future research should 
attempt to define and further examine the energizing effect of concurrent walking, and 
the further energizing effect of activities of increased physical effort on conversational 
speech intensity in individuals with PD and healthy adults.  
The present study found no significant difference in conversational speech rate 
between groups and across all walking and talking conditions. Future research should 
consider investigating speech rate in individuals with PD using additional measures such 
as the frequency and duration of conversational pauses or the variability and acceleration 
of intra-utterance speech rate. 
The secondary objective of the present study was to examine the effect of 
concurrent talking on walking speed and stride length in individuals with PD and healthy 
age-equivalent controls. The results demonstrate that individuals with PD have a reduced 
gait velocity and shorter stride length relative to controls across all walking speed and 
talking conditions. In addition, concurrent walking and talking was associated with 
reduced walking speed and stride length values across all of the walking speed 
conditions, relative to walking only, in both participant groups. An interesting finding 
was that both participant groups did not actually produce a two times faster or two times 
slower waling speed in the particular walking speed conditions. For example, PD 
participants scaled walking speed by approximately 33% in the fast walking condition, 
 99
instead of 100%. Future research should investigate the actual-to-perceived scaling of 
walking speed in individuals with PD and healthy adults.   
In general, the results of this study provide important new information about the 
effect of concurrent walking on speech motor performance in PD. In addition, this study 
provides support for an energizing effect of concurrent walking conditions on 
conversational speech intensity. This energizing effect may be an important consideration 
in the future development of assessment and treatment procedures for individuals with 
low speech intensity in PD.  
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Appendix B. PD Participant Letter of Information 
 
LETTER OF INFORMATION 
Participants with Parkinson’s disease 
 
STUDY TITLE 
Effects of concurrent walking tasks and interlocutor distance on conversational speech in 
Parkinson’s disease.  
 
PRINCIPAL INVESTIGATOR 
Scott Adams, Ph.D. 
Professor 
School of Communication Sciences and Disorders; Clinical Neurological Sciences 
University of Western Ontario 
 
CO-INVESTIGATORS 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders 
University of Western Ontario 
 
Dr. Mandar Jog, MD, FRCPC 
Director, Movement Disorders Program,  
London Health Sciences Centre, University Campus and 
University of Western Ontario 
 
Cassandra McCaig 
MSc. Candidate,  
Health and Rehabilitation Sciences 
University of Western Ontario 
 
INTRODUCTION 
 
This letter of information describes a research study and what you may expect if you 
decide to participate.  You should read the letter carefully and ask the person discussing 
this with you any questions that you may have before making a decision whether or not to 
participate.  This form contains important information and telephone numbers, so you 
should keep this copy for future reference. If you decide not to participate in this study, 
the decision will not be held against you and will not affect your treatment in any way.  
 
You are being asked to participate in this research study because you are an individual 
with reduced speech intensity and Parkinson’s disease. The purpose of this study is to 
investigate the effects of various concurrent tasks and interlocutor distance on speech 
parameters in Parkinson’s disease.  An example of tasks being performed concurrently is 
speaking while talking.  
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This study will involve 40 participants. Twenty of the participants will have reduced 
speech intensity and Parkinson’s disease. The other twenty participants will not have any 
neurological conditions. Information about participants will be collected from patient 
charts and person-to-person interviews by the principal experimenter or another 
designated member of the research team. This will include information about the 
participant’s date of birth, general medical history, neurological history, and speech and 
hearing history. 
 
In this study, you will be asked to perform a variety of separate and concurrent speech 
and walking tasks for a total of 13 experimental conditions. The experimental conditions 
involve evaluating several acoustic parameters of speech in isolation, while walking, and 
at an interlocutor distance of 1-metre or 6-metres. The acoustic measures will include 
average speech rate and average speech intensity. Speech tasks will involve engaging in a 
conversation with the experimenter for approximately 2-3 minutes about a familiar topic. 
The conversational topics will include favourite vacations, interests, hobbies, relatives, 
occupational experiences, etc . The conversations will take place with the experimenter 
positioned at either a 1-meter or 6-meter interlocutor distance from you. The gait 
measures include a stride length and walking rate. The walking tasks will involve 5 
different tasks. These include 1) sitting, 2) standing, 3) walking at a normal or habitual 
speed, 4) walking at a speed that is self-perceived to be two times slower than the 
habitual speed, and 5) walking at a speed that is self-perceived to be two times faster than 
habitual. During all of the conditions, you will wear a headset microphone that will 
record the speech on a laptop computer. After you complete the experimental trials, we 
will conduct a standard hearing assessment. During the standard hearing assessment, you 
will hear a variety of sounds at different intensities and frequencies. If you agree to 
participate you will be asked to come one time to Althouse College at the University of 
Western Ontario for testing. It is anticipated that the total time for this experiment and the 
hearing test will be no more than 90 minutes.   
 
The experimental procedures will require very brief and intermittent physical effort, and 
there is no known discomfort or risk involved in performing them.  You will be asked to 
walk down and back a 25-metre corridor and you will be given rest breaks approximately 
every five minutes or more frequently if required. 
 
The procedures that will be used during this study are experimental in nature and will not 
provide any direct benefit to the participant’s medical condition, however, it is anticipated 
that this research will provide new information about the effects of conversational speech 
produced at different loudness levels on walking efficiency and gait symptom severity in 
PD, and that these results will have important implications for the development of new 
speech and gait therapy programs in PD. Financial compensation will not be provided 
upon completion of this study. Free parking will be provided while you are visiting the 
gymnasium at Althouse College. 
 
Participation in this study is voluntary.  You may refuse to participate, refuse to answer any 
questions, or withdraw from the study at any time with no effect on your future care. 
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All of the information obtained in this study will be held in strict confidence.  Your name 
and any identifying information will be removed from the data.  If the results of the study 
are published, your name will not be used and no information that discloses your identity 
will be released or published.  
 
Throughout the study, all confidential information will be preserved in a locked filing 
cabinet in the Principal Investigator’s laboratory at Elborn College, University of 
Western Ontario. 
 
If requested, you will be provided with a copy of any publication related to the results of 
this study when it becomes available. 
 
If you have any questions or would like additional information about this study, please 
contact Professor Scott Adams at the School of Communication Sciences and Disorders, 
Elborn College, University of Western Ontario, London, Ontario, N6G 1H1 (Phone: (519) 
661-2111 x 88941). 
 
If you have any questions about the conduct of this study or your rights as a research subject 
you may contact Dr. David Hill, Scientific Director, Lawson Health Research Institute, at 
(519) 667-6649. 
 
If you agree to participate in this study, please sign the consent form on the next page. 
 
 
Sincerely, 
 
 
 
 
Scott Adams, Ph.D.  
Professor  
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Appendix C. Control Participant Letter of Information 
 
LETTER OF INFORMATION 
Control Participants 
 
STUDY TITLE 
Effects of concurrent walking tasks and interlocutor distance on conversational speech in 
Parkinson’s disease.  
 
PRINCIPAL INVESTIGATOR 
Scott Adams, Ph.D. 
Professor 
School of Communication Sciences and Disorders; Clinical Neurological Sciences 
University of Western Ontario 
 
CO-INVESTIGATORS 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders 
University of Western Ontario 
 
Dr. Mandar Jog, MD, FRCPC 
Director, Movement Disorders Program,  
London Health Sciences Centre, University Campus and 
University of Western Ontario 
 
Cassandra McCaig 
MSc. Candidate,  
Health and Rehabilitation Sciences 
University of Western Ontario 
 
INTRODUCTION 
 
This letter of information describes a research study and what you may expect if you 
decide to participate.  You should read the letter carefully and ask the person discussing 
this with you any questions that you may have before making a decision whether or not to 
participate.  This form contains important information and telephone numbers, so you 
should keep this copy for future reference. If you decide not to participate in this study, 
the decision will not be held against you and will not affect your treatment in any way.  
 
The purpose of this study is to investigate the effects of various concurrent tasks and 
interlocutor distance on speech parameters in Parkinson’s disease. An example of tasks 
being performed concurrently is talking while walking.  
 
This study will involve 40 participants. Twenty of the participants will have reduced 
speech intensity and Parkinson’s disease. The other twenty participants will not have any 
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neurological conditions. Information about participants will be collected from patient 
charts and person-to-person interviews by the principal experimenter or another 
designated member of the research team. This will include information about the 
participant’s date of birth, general medical history, neurological history, and speech and 
hearing history. 
  
In this study, you will be asked to perform a variety of separate and concurrent speech 
and walking tasks for a total of 13 experimental conditions. The experimental conditions 
involve evaluating several acoustic parameters of speech in isolation, while walking, and 
at an interlocutor distance of 1-metre or 6-metres. The acoustic measures will include 
average speech rate and average speech intensity. Speech tasks will involve engaging in a 
conversation with the experimenter for approximately 2-3 minutes about a familiar topic. 
The conversational topics will include favourite vacations, interests, hobbies, relatives, 
occupational experiences, etc . The conversations will take place with the experimenter 
positioned at either a 1-meter or 6-meter interlocutor distance from you. The gait 
measures include a stride length and walking rate. The walking tasks will involve 5 
different tasks. These include 1) sitting, 2) standing, 3) walking at a normal or habitual 
speed, 4) walking at a speed that is self-perceived to be two times slower than the 
habitual speed, and 5) walking at a speed that is self-perceived to be two times faster than 
habitual. During all of the conditions, you will wear a headset microphone that will 
record the speech on a laptop computer. After you complete the experimental trials, we 
will conduct a standard hearing assessment. During the standard hearing assessment, you 
will hear a variety of sounds at different intensities and frequencies. If you agree to 
participate you will be asked to come one time to Althouse College at the University of 
Western Ontario for testing. It is anticipated that the total time for this experiment and the 
hearing test will be no more than 90 minutes.   
 
The experimental procedures will require very brief and intermittent physical effort, and 
there is no known discomfort or risk involved in performing them.  You will be asked to 
walk down and back a 25-metre corridor and you will be given rest breaks approximately 
every five minutes or more frequently if required. 
 
The procedures that will be used during this study are experimental in nature and will not 
provide any direct benefit to the participant’s medical condition, however, it is anticipated 
that this research will provide new information about the effects of conversational speech 
produced at different loudness levels on walking efficiency and gait symptom severity in 
PD, and that these results will have important implications for the development of new 
speech and gait therapy programs in PD. Financial compensation will not be provided 
upon completion of this study. Free parking will be provided while you are visiting the 
lab at Elborn College. 
 
Participation in this study is voluntary.  You may refuse to participate, refuse to answer any 
questions, or withdraw from the study at any time with no effect on your future care. 
  
All of the information obtained in this study will be held in strict confidence.  Your name 
and any identifying information will be removed from the data.  If the results of the study 
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are published, your name will not be used and no information that discloses your identity 
will be released or published.  
 
Throughout the study, all confidential information will be preserved in a locked filing 
cabinet in the Principal Investigator’s laboratory at Elborn College, University of 
Western Ontario. 
 
If requested, you will be provided with a copy of any publication related to the results of 
this study when it becomes available. 
 
If you have any questions or would like additional information about this study, please 
contact Professor Scott Adams at the School of Communication Sciences and Disorders, 
Elborn College, University of Western Ontario, London, Ontario, N6G 1H1 (Phone: (519) 
661-2111 x 88941). 
 
If you have any questions about the conduct of this study or your rights as a research subject 
you may contact Dr. David Hill, Scientific Director, Lawson Health Research Institute, at 
(519) 667-6649. 
 
If you agree to participate in this study, please sign the consent form on the next page. 
 
 
Sincerely, 
 
 
 
 
Scott Adams, Ph.D. 
Professor  
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Appendix D. Participant Consent Form 
 
CONSENT FORM 
Participant with Parkinson’s disease 
 
STUDY TITLE 
Effects of concurrent walking tasks and interlocutor distance on conversational speech in 
Parkinson’s disease.  
 
PRINCIPAL INVESTIGATOR 
Scott Adams, Ph.D. 
Professor 
School of Communication Sciences and Disorders; Clinical Neurological Sciences 
Western University 
 
CO-INVESTIGATORS 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director, Movement Disorders Program,  
London Health Sciences Centre, University Campus and 
Western University 
 
Cassandra McCaig 
MSc. Candidate,  
Health and Rehabilitation Sciences 
Western University 
 
 
I have read the Letter of Information (have had the nature of the study explained to me), 
and I agree to participate. All questions have been answered to my satisfaction. 
 
 
 
 
Signature of Research Subject        Printed Name    Date 
 
 
 
 
Signature of Person Obtaining Consent Printed Name    Date 
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Appendix E. Participant Intake Survey 
 
Parkinson’s Speech Study 
 
Section 1: Demographic Information 
Name:  ____________________________________________________ 
Phone Number: _____________________________________________ 
Birth Date (MM/DD/YYYY):   ________________________________ Age:  _______ 
Occupation: ________________________________________________ 
Gender:   Male  Female 
Parkinson’s Disease □ Control  □      Date of Diagnosis: _____________ 
Time since last PD medication: _________________ 
Time until next PD medication: _________________ 
Type of medication:  Sinemet □ Other □: ____________________ 
Section 2: Hearing Screening 
Hearing Threshold:    
 Right Left 
500 dB   
1000 dB   
2000 dB   
4000 dB   
 
Section 3: Speech, Language, Hearing or Neurological Impairment 
Ever been diagnosed with a speech impairment? Yes  □ No  □ 
 If yes, please indicate the diagnosis: ______________________________________ 
Ever been diagnosed with a language impairment? Yes  □ No  □ 
 If yes, please indicate the diagnosis: ______________________________________ 
Ever been diagnosed with a hearing impairment? Yes  □ No  □ 
 If yes, please indicate the diagnosis: ______________________________________ 
Ever been diagnosed with a neurological impairment? Yes  □ No  □ 
 If yes, please indicate the diagnosis: ______________________________________ 
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Appendix F. 3 Way ANOVA: Speech Intensity 
 
 
 
Index for 3 Way ANOVA: Speech Intensity 
*code 1 = control participants, code 2 = PD participants, interloc 1 = one meter interlocutor 
distance, interloc 2 = six meters interlocutor distance, walking 1 = sitting, walking 2 = standing, 
walking 3 = normal walking speed, walking 4 = fast walking speed, walking 5 = slow walking 
speed, c1 = sitting at one meter interlocutor distance, c2 = sitting at six meters interlocutor 
distance, c3 = standing at one meter interlocutor distance, c4 = standing at six meters interlocutor 
distance, c6 = walking normal speed at one meter interlocutor distance, c7 = walking normal 
speed at six meters interlocutor distance, c8 = walking fast speed at one meter interlocutor 
distance, c9 = walking fast speed at six meters interlocutor distance, c10 = walking slow speed at 
one meter interlocutor distance, c11 = walking fast speed at six meters interlocutor distance. 
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Appendix G. T-Test: Effect of Walking Speed on Speech Intensity 
 
Index for T-Tests 
c6-c11 = control participants, c6p-c11p = PD participants, c6 = normal walking speed at one 
meter interlocutor distance, c7 = normal walking speed at six meters interlocutor distance, c8 = 
fast walking speed at one meter interlocutor distance, c9 = fast walking speed at six meters 
interlocutor distance, c10 = slow walking speed at one meter interlocutor distance, c11 = slow 
walking speed at six meters interlocutor distance, c6p = normal walking speed at one meter 
interlocutor distance, c7p = normal walking speed at six meters interlocutor distance, c8p = fast 
walking speed at one meter interlocutor distance, c9p = fast walking speed at six meters 
interlocutor distance, c10p = slow walking speed at one meter interlocutor distance, c11p = slow 
walking speed at six meters interlocutor distance 
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Appendix H. 3 Way ANOVA: Speech Rate 
 
 
Index for 3 Way ANOVA: Speech Rate 
*code 1 = control participants, code 2 = PD participants, interloc 1 = one meter interlocutor 
distance, interloc 2 = six meters interlocutor distance, walking 1 = sitting, walking 2 = standing, 
walking 3 = normal walking speed, walking 4 = fast walking speed, walking 5 = slow walking 
speed, cr1 = sitting at one-meter, cr2 = sitting at six meters, cr3 = standing at one meter, cr4 = 
standing at six meters, cr6 = walking normal speed at one meter, cr7 = walking normal speed at 
six meters, cr8 = walking fast speed at one meter, cr9 = walking fast speed at six meters, cr10 = 
walking slow speed at one meter, cr11 = walking fast speed at six meters. 
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Appendix I. 3 Way ANOVA: Walking Speed and Concurrent Talking 
 
 
Index for 3 Way ANOVA: Walking Speed and Concurrent Talking 
*code 1 = control participants, code 2 = PD participants, speed 1 = slow, speed 2 = normal, speed 
3 = fast, talk 1 = talking and walking, talk 2 = walking only, slow1 = talking while walking at a 
slow speed, slowNT = walking at slow speed without talking, norm 1 = talking while walking at 
normal speed, normNT = walking at normal speed without talking, fast1 = talking and walking at 
fast speed, fastNT = walking at fast speed without talking 
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Appendix J. 3 Way ANOVA: Walking Speed and Interlocutor Distance 
 
 
Index for 3 Way ANOVA: Walking Speed and Interlocutor Distance 
*code 1 = control participants, code 2 = PD participants, interloc 1 = one meter interlocutor 
distance, interloc 2 = six meters interlocutor distance, slow1 = walking slow at one meter 
interlocutor distance, slow6 = walking slow at six meters interlocutor distance, norm1 = walking 
normal at one meter interlocutor distance, norm6 = walking normal at six meters interlocutor 
distance, fast1 = walking fast at one meter interlocutor distance, fast6 = walking fast at six meters 
interlocutor distance 
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Appendix K. 3 Way ANOVA: Stride Length and Concurrent Talking 
 
 
Index for 3 Way ANOVA: Stride Length and Concurrent Talking 
*code 1 = control participants, code 2 = PD participants, speed 1 = slow, speed 2 = normal, speed 
3 = fast, talk 1 = talking and walking, talk 2 = walking only, slow1 = talking while walking at a 
slow speed, slowNT = walking at slow speed without talking, norm 1 = talking while walking at 
normal speed, normNT = walking at normal speed without talking, fast1 = talking and walking at 
fast speed, fastNT = walking at fast speed without talking 
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Appendix L. 3 Way ANOVA: Stride Length and Interlocutor Distance 
 
 
Index for 3 Way ANOVA: Stride Length and Interlocutor Distance 
*code 1 = control participants, code 2 = PD participants, interloc 1 = one meter interlocutor 
distance, interloc 2 = six meters interlocutor distance, slow1 = walking slow at one meter 
interlocutor distance, slow6 = walking slow at six meters interlocutor distance, norm1 = walking 
normal at one meter interlocutor distance, norm6 = walking normal at six meters interlocutor 
distance, fast1 = walking fast at one meter interlocutor distance, fast6 = walking fast at six meters 
interlocutor distance 
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